
<html lang="en"     class="pb-page"  data-request-id="c8125848-b1bd-4c98-899e-791cf9297fa8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2012.55.issue-7;article:article:10.1021/jm300117u;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer" /></meta><meta name="dc.Creator" content="Zhenfeng  Duan" /></meta><meta name="dc.Creator" content="Xin  Li" /></meta><meta name="dc.Creator" content="Haoxi  Huang" /></meta><meta name="dc.Creator" content="Wei  Yuan" /></meta><meta name="dc.Creator" content="Shao-Liang  Zheng" /></meta><meta name="dc.Creator" content="Xianzhe  Liu" /></meta><meta name="dc.Creator" content="Zhan  Zhang" /></meta><meta name="dc.Creator" content="Edwin  Choy" /></meta><meta name="dc.Creator" content="David  Harmon" /></meta><meta name="dc.Creator" content="Henry  Mankin" /></meta><meta name="dc.Creator" content="Francis  Hornicek" /></meta><meta name="dc.Description" content="Development of multidrug resistance (MDR) during chemotherapy is a fundamental obstacle associated with cancer care. Prior studies have identified (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)m..." /></meta><meta name="Description" content="Development of multidrug resistance (MDR) during chemotherapy is a fundamental obstacle associated with cancer care. Prior studies have identified (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)m..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 22, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300117u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300117u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300117u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300117u" /></link>
        
    
    

<title>Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300117u" /></meta><meta property="og:title" content="Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0006.jpeg" /></meta><meta property="og:description" content="Development of multidrug resistance (MDR) during chemotherapy is a fundamental obstacle associated with cancer care. Prior studies have identified (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (5) (NSC23925) to be a small molecule agent that reverses MDR in cancer cells. We synthesized all four isomers of 5 and analyzed them by liquid chromatography–mass spectrometry (LCMS). Structure–activity relationships for reversing MDR were evaluated. Isomer 11 demonstrated the most potent activity. 11 reversed MDR in several drug-resistant cell lines expressing Pgp, including ovarian, breast, colon, uterine, and sarcoma cancer. 11 resensitized these cell lines to paclitaxel, doxorubicin, mitoxantrone, vincristine, and trabectedin with no effect on cell sensitivity to cisplatin, topotecan, and methotrexate. 11 significantly enhanced in vivo antitumor activity of paclitaxel in MDR xenograft models, without increasing the level of paclitaxel toxicity. In conclusion, 11 and derivatives of this compound may hold therapeutic value in the treatment of MDR-dependent cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300117u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300117u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300117u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300117u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300117u&amp;href=/doi/10.1021/jm300117u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3113-3121</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201537d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201540h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenfeng++Duan">Zhenfeng Duan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Li">Xin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haoxi++Huang">Haoxi Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Yuan">Wei Yuan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shao-Liang++Zheng">Shao-Liang Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianzhe++Liu">Xianzhe Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhan++Zhang">Zhan Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edwin++Choy">Edwin Choy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Harmon">David Harmon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry++Mankin">Henry Mankin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francis++Hornicek">Francis Hornicek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">#</span> <span class="aff-text">Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">†</span> <span class="aff-text">Chengdu ChemPartner Co., Ltd., Floor 3, Building 3, Tianfu Life Science Park, No. 88, Keyuan South Road, Hi-Tech Zone, Chengdu, 610041, People's Republic of China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">§</span> <span class="aff-text">The Third Affiliated Hospital of Zhengzhou University, People's Republic of China</span></div><div class="corresp-info"><strong>*</strong>Telephone: (617) 724-3144. Fax: (617) 726-3883. E-mail: <a href="/cdn-cgi/l/email-protection#f29687939c88b29a979e9b8adc9f959adc9a938084938096dc979687"><span class="__cf_email__" data-cfemail="751100141b0f351d10191c0d5b18121d5b1d1407031407115b101100">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300117u&amp;href=/doi/10.1021%2Fjm300117u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3113–3121</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 8, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 November 2011</li><li><span class="item_label"><b>Published</b> online</span>22 March 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300117u" title="DOI URL">https://doi.org/10.1021/jm300117u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3113%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhenfeng%2BDuan%252C%2BXin%2BLi%252C%2BHaoxi%2BHuang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D7%26contentID%3Djm300117u%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2B%25282-%25284-Methoxyphenyl%2529-4-quinolinyl%2529%25282-piperidinyl%2529methanol%2B%2528NSC23925%2529%2BIsomers%2BTo%2BReverse%2BMultidrug%2BResistance%2Bin%2BCancer%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3121%26publicationDate%3DApril%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300117u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1567</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300117u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhenfeng&quot;,&quot;last_name&quot;:&quot;Duan&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Haoxi&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Shao-Liang&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Xianzhe&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Zhan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Edwin&quot;,&quot;last_name&quot;:&quot;Choy&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Harmon&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;Mankin&quot;},{&quot;first_name&quot;:&quot;Francis&quot;,&quot;last_name&quot;:&quot;Hornicek&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;3113-3121&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300117u&quot;},&quot;abstract&quot;:&quot;Development of multidrug resistance (MDR) during chemotherapy is a fundamental obstacle associated with cancer care. Prior studies have identified (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (5) (NSC23925) to be a small molecule agent that reverses MDR in cancer cells. We synthesized all four isomers of 5 and analyzed them by liquid chromatography–mass spectrometry (LCMS). Structure–activity relationships for reversing MDR were evaluated. Isomer 11 demonstrated the most potent activity. 11 reversed MDR in several drug-resistant cell lines expressing Pgp, including ovarian, breast, colon, uterine, and sarcoma cancer. 11 resensitized these cell lines to paclitaxel, doxorubicin, mitoxantrone, vincristine, and trabectedin with no effect on cell sensitivity to cisplatin, topotecan, and methotrexate. 11 significantly enhanced in vivo antitumor activity of paclitaxel in MDR xenograft models, without increasing the level of paclitaxel toxicity. In conclusion, 11 and derivatives of this compound may hold&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300117u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300117u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300117u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300117u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300117u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300117u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300117u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300117u&amp;href=/doi/10.1021/jm300117u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300117u" /></input><a href="/doi/pdf/10.1021/jm300117u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300117u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300117u%26sid%3Dliteratum%253Aachs%26pmid%3D22400811%26genre%3Darticle%26aulast%3DDuan%26date%3D2012%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2B%25282-%25284-Methoxyphenyl%2529-4-quinolinyl%2529%25282-piperidinyl%2529methanol%2B%2528NSC23925%2529%2BIsomers%2BTo%2BReverse%2BMultidrug%2BResistance%2Bin%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D7%26spage%3D3113%26epage%3D3121%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290768" title="Antineoplastic agents">Antineoplastic agents</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jmcmar.2012.55.issue-7/production/jmcmar.2012.55.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Development of multidrug resistance (MDR) during chemotherapy is a fundamental obstacle associated with cancer care. Prior studies have identified (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (<b>5</b>) (NSC23925) to be a small molecule agent that reverses MDR in cancer cells. We synthesized all four isomers of <b>5</b> and analyzed them by liquid chromatography–mass spectrometry (LCMS). Structure–activity relationships for reversing MDR were evaluated. Isomer <b>11</b> demonstrated the most potent activity. <b>11</b> reversed MDR in several drug-resistant cell lines expressing Pgp, including ovarian, breast, colon, uterine, and sarcoma cancer. <b>11</b> resensitized these cell lines to paclitaxel, doxorubicin, mitoxantrone, vincristine, and trabectedin with no effect on cell sensitivity to cisplatin, topotecan, and methotrexate. <b>11</b> significantly enhanced in vivo antitumor activity of paclitaxel in MDR xenograft models, without increasing the level of paclitaxel toxicity. In conclusion, <b>11</b> and derivatives of this compound may hold therapeutic value in the treatment of MDR-dependent cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A major obstacle to cancer therapy is multidrug resistance (MDR), which can arise from either intrinsic or acquired mechanisms of resistance.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> One of the molecular mechanisms for MDR is overexpression of plasma membrane glycoprotein (Pgp).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Pgp is the gene product of MDR1(ABCB1), a member of the ABC (ATP binding cassette) superfamily of a 170 kDa transporter protein, and it acts as an energy-dependent (ATP) cancer drug efflux by pumping drugs out of the cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Overexpression of Pgp in tumor cells prevents adequate intracellular accumulation of a large number of cytotoxic drugs including anthracyclines (doxorubicin, daunorubicin), anthracenedione (mitoxantrone), vinca alkaloids (vinblastine, vincristine), taxanes (paclitaxel, docetaxel), and many others.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> A series of homologous ABC proteins such as multidrug-resistance proteins (MRPs) and breast cancer resistance protein (BCRP) have also been discovered.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">Pgp is a major protein associated with MDR and has a low level expression in normal tissues. A series of compounds that interact with Pgp and block drug efflux have been reported to reverse the MDR phenotype.<a onclick="showRef(event, 'ref1 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref8">(1, 8)</a> Previous studies have focused on MDR-reversing agents such as verapamil, cyclosporine A, valspodar (PSC833, Amdray),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and biricodar (VX710, INCEL).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Unfortunately, these compounds, initially developed for pharmacological uses other than MDR reversal, are relatively nonspecific and weak in potency.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> For most of these compounds, clinical toxicities associated with their use at concentrations required to inhibit Pgp have precluded their widespread use. For example, the serum concentration of the calcium channel blocker verapamil that is required to produce in vitro reversal of MDR cannot be achieved in patients because of significant cardiotoxicities. Valspodar and biricodar have shown significant pharmacokinetic interaction with paclitaxel.<a onclick="showRef(event, 'ref1 ref3 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref3 ref10 ref11">(1, 3, 10, 11)</a> The addition of biricodar (biricodar blood steady-state concentrations of 10 μM were sustained at a dosage of 120 mg/m<sup>2</sup> per hour) to doxorubicin and vincristine therapy did not significantly increase antitumor activity or survival.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Previously, in an attempt to identify novel small molecules that are more potent and selective as MDR inhibitors, we screened 2000 small molecule compounds from the NCI Diversity Set library to look for compounds that can reverse MDR in drug-resistant cell lines. We identified 2 out 2000 compounds, tetrandrine (NSC77037)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (<b>5</b>) (NSC23925), as compounds with the highest activities as MDR reversal agents.<a onclick="showRef(event, 'ref5 ref13'); return false;" href="javascript:void(0);" class="ref ref5 ref13">(5, 13)</a></div><div class="NLM_p"><b>5</b> is the most potent MDR reversing compound that we observed in the NCI compound set.<a onclick="showRef(event, 'ref5 ref14'); return false;" href="javascript:void(0);" class="ref ref5 ref14">(5, 14)</a> In comparison with tetrandrine, <b>5</b> is a unique compound with essentially very little chemical or biologic characterization since its synthesis as an antimalarial agent in the 1940s.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Analysis of the structure of <b>5</b> indicates that it has two chiral centers which lead to four different stereoisomers <b>8</b>,<b> 9</b>, <b>10</b>, and <b>11</b>. In theory, each of the compound <b>5</b> isomers may have distinct bioactivities.</div><div class="NLM_p last">In this study, we synthesized and separated all four isomers of <b>5</b> and biologically characterized each of them in several multidrug-resistant cell lines. The most potent <b>5</b> isomer, <b>11</b>, was selected for further evaluation in vivo in a multidrug-resistant ovarian cancer xenograft mouse model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By using the route as indicated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the synthesis of all four isomers of <b>5</b> was accomplished with Pfitzinger’s method.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> 2-(4-Methoxyphenyl)quinoline-4-carboxylic acid (<b>1</b>) was prepared in 50% yield from indoline-2,3-dione and 1-(4-methoxyphenyl)ethanone, and then it was esterified to afford methyl 2-(4-methoxyphenyl)quinoline-4-carboxylate (<b>2</b>) in 70% yield. Using n-BuLi as a base, 2-bromopyridine was reacted with <b>2</b> to give (2-(4-methoxyphenyl)quinolin-4-yl)(pyridin-2-yl)methanone (<b>3</b>) in 91% yield. Subsequent reduction of <b>3</b> by NaBH<sub>4</sub> afforded (2-(4-methoxyphenyl)quinolin-4-yl)(pyridin-2-yl)methanol (<b>4</b>) in 60% yield. Hydrogenation of <b>4</b> with 30 mol % PtO<sub>2</sub> in a mixture of methanol and concd HCl (40:1) afforded (2-(4-methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol (<b>5</b>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Because attempts to separate isomers of <b>5</b> by chiral HPLC failed to get optically pure products, derivation of <b>5</b> was carried out, and Boc-protected derivatives <b>6</b> and <b>7</b> were prepared and separated away from each other on silica gel chromatography. The structure of <b>6</b> and <b>7</b> was confirmed to be threo isomer and erythro isomer, respectively, according to the common trend in which the coupling constant of CH(NH)CH(OH) of the erythro isomer (<sup>3</sup><i>J</i>-erythro) is smaller than that of threo isomer (<sup>3</sup><i>J</i>-threo).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Then threo isomer <b>6</b> was separated by chiral HPLC to give optically pure Boc-<b>8</b> and Boc-<b>9</b>, and erythro isomer <b>7</b> gave optically pure Boc-<b>10</b> and Boc-<b>11</b>. Finally deprotection of these Boc-derivatives of <b>8</b> to <b>11</b> by HCl–EtOH solution afforded four isomers <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b>. We cultivated the single crystal from these synthesized compounds and determined the absolute configuration for all four isomers (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 1">Supporting Information Figure 1</a>) which confirmed the judgment on the erythro/threo isomers. Liquid chromatography–mass spectrometry (LCMS, chiral HPLC) analysis demonstrated that the four isomers <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b> have the desired mass with significant purity (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 2">Supporting Information Figure 2</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>5</b> (NSC23925) Isomers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(4-methoxyphenyl)ethanone, KOH, EtOH, 85 °C, 24 h, 50%; (b) concd H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux overnight, 70%; (c) 2-bromopyridine, n-BuLi, Et<sub>2</sub>O–THF, −78 °C, 2 h, 91%; (d) NaBH<sub>4</sub>, EtOH, 0 °C, 1 h, 60%; (e) H<sub>2</sub>, PtO<sub>2</sub>, concd HCl, MeOH, 20 °C, 2 h; (f) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 to rt,overnight; (g) chiral HPLC; (h) HCl/EtOH, 20 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Biological Evaluation and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Identification of <b>11</b> as the Most Potent Isomer That Reverses MDR in Human Cancer Cell Lines</h3><div class="NLM_p">Structure–activity relationships of four <b>5</b> isomers for reversing MDR were evaluated in human ovarian cancer MDR cell line SKOV-3<sub>TR</sub> by MTT assay. We observed that among the <b>5</b> isomers, <b>11</b> is the most potent one in reversing drug resistance (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). <b>8</b> and <b>9</b> showed modest but lesser activity, while <b>10</b> showed the least potency.Further studies showed that <b>11</b> is able to reverse paclitaxel, doxorubicin, and mitoxantrone resistance in human breast cancer MDR cell line MCF-7adr and human colon cancer MDR cell line SW480<sub>TR</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In addition, <b>11</b> is much more potent (10 to 60 fold) than that of known drug resistance reversing agents verapamil or CsA (data not shown). In summary, <b>11</b> is able to reverse MDR in several MDR cell lines, including ovarian, breast, uterine, colon, and sarcoma MDR cancer cell lines to paclitaxel, docetaxel, doxorubicin, vincristine, daunorubicin, gemcitabine, trabectedin (ET-743, Yondelis),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and mitoxantrone. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows representative findings of <b>11</b> on reversing drug resistance in ovarian, breast, and colon MDR cell lines while similar results have been found in uterine sarcoma, osteosarcoma, and Ewing sarcoma cell lines (data not shown). In the profile of reverse drug resistance to chemotherapy drugs, the results showed that <b>11</b> could reverse drug resistance to paclitaxel, doxorubicin, mitoxantrone, vincristine, and ET-743 but has no significant effects on drug sensitivities of cisplatin, carboplatin, topotecan, and methotrexate. Overexpression of MDR1 is a well-known mechanism of drug resistance for paclitaxel, doxorubicin, mitoxantrone, and vincristine. In contrast, the mechanism of drug resistance for cisplatin, carboplatin, and topotecan are thought to be due to increased DNA repair mechanisms. Interestingly, our previous study showed reversal of MDR by <b>5</b> was through selective and potent inhibition of MDR1 (Pgp) function. Furthermore, we also evaluated the effects of <b>11</b> on MDR1 (Pgp)-independent MRP1 or BCRP-mediated drug resistance in H-69AR and MCF-7/MX cell lines. The results showed that <b>11</b> was unable to reverse drug resistance in these non-Pgp-expressing drug-resistant cell lines, suggesting that <b>11</b> activity is specific for Pgp.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of <b>5</b> isomers on reverse drug resistance in SKOV-3<sub>TR</sub> cell line. Cells were treated with the paclitaxel and isomers (<b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b>) in RPMI1640 complete media at the indicated concentrations. The relative sensitivity of each line to paclitaxel was determined by MTT analysis 6 days posttreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reverse multidrug resistance isomer <b>11</b> in MCF-7adr and SW480<sub>TR</sub> cell lines. Cells were treated with paclitaxel, doxorubicin, or mitoxantrone and isomer <b>11</b> in RPMI1640 complete media at the indicated concentrations. The relative sensitivity of each line to the indicated drugs was determined by MTT analysis 6 days posttreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Isomer <b>11</b> on Reverse Drug Resistance in MDR Cell Lines<a class="ref internalNav" href="#t1f1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">SKOV-3<sub>TR</sub> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">MCF-7adr IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">SW480<sub>TR</sub> IC<sub>50</sub>(μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pactlitaxel</td><td class="colsep0 rowsep0" align="char" char="±">0.57 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.1 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.04 (2)</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.1 (1.3)</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.01 (1.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.5 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.08 ± 0.06 (7)</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.03 (4)</td><td class="colsep0 rowsep0" align="char" char="±">0.016 ± 0.006 (8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>1 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.03 (28)</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.02 (12)</td><td class="colsep0 rowsep0" align="char" char="±">0.009 ± 0.002 (13)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doxorubicin</td><td class="colsep0 rowsep0" align="char" char="±">38.5 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.1 μM</td><td class="colsep0 rowsep0" align="char" char="±">24.6 ± 1.2 (2)</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.4 (1.4)</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1 (1.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.5 μM</td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 0.5 (9)</td><td class="colsep0 rowsep0" align="char" char="±">0.96 ± 0.22 (4)</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.08 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>1 μM</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.3 (32)</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.06 (15)</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.04 (8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mitoxantrone</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.27 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.1 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.37 ± 0.05 (1.2)</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.001 (1.1)</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.03 (1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>0.5 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.02 (2.6)</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.02 (3)</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.03 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">with <b>11</b>1 μM</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.01 (8)</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01(6)</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.01 (14)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1f1"><div class="footnote" id="t1f1"><sup>a</sup><p class="last">Cell survival was determined by MTT assay as described in Materials and Methods. IC<sub>50</sub> is the concentration of drug (μM) that produced 50% inhibition of cell growth. Results were calculated from one experiment with triplicate wells. The numbers in the parentheses represent fold-reversal of drug resistance (IC<sub>50</sub> of drugs divided by IC<sub>50</sub> of drugs with <b>11</b>).</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> <b>11</b> Modulates Pgp-Mediated Uptake and Efflux of Calcein AM</h3><div class="NLM_p">Reversal of MDR is usually displayed as an increased intracellular accumulation of chemotherapeutic drugs. We examined the effects of <b>11</b> on the uptake and efflux of calcein AM in MCF-7adr and SW480<sub>TR</sub>. Fluorescence microscopic analysis showed <b>11</b>’s ability to increase intracellular accumulation of calcein AM in these cell lines in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). <b>11</b> has a prominent effect on the accumulation of calcein AM in these cells starting at a concentration as low as 10 nM. Half-maximal reversal of accumulation deficit was observed at 100 nM and near maximal at 500 nM.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Calcein AM efflux from isomer <b>11</b>-treated MCF-7adr and SW480<sub>TR</sub> cell line cells. The calcein AM assay was optimized and performed using the Vybrant Multidrug Resistance kit. Cells were seeded at 50 000 cells/well (100 μL of culture medium) in a 96-well plate and incubated for 24 h. MCF-7adr or SW480<sub>TR</sub> cells in triplicate were treated with <b>11</b> for 1 h and then incubated in calcein AM for 30 min. The cell fluorescence images were acquired by a fluorescence microscope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Combination of <b>11</b> and Doxorubicin Induces Apoptosis in MDR Cancer Cells</h3><div class="NLM_p">The effect of <b>11</b> on the doxorubicin induction of apoptosis was assessed in MCF-7adr or SW480<sub>TR</sub> cell lines. The cells were treated with either doxorubicin (0.5 μM) alone, <b>11</b> (1 μM) alone, or with a combination of doxorubicin and <b>11</b> for 72 h. Apoptosis was scored using the M30-Apoptosense ELISA assay. The combination of doxorubicin and <b>11</b> resulted in significantly greater cell death as compared with doxorubicin or <b>11</b> alone (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Additionally, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide) cytotoxicity assay also showed that <b>11</b> has a synergistic effect on doxorubicin-induced cell death.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Isomer <b>11</b> in combination with doxorubicin significantly induces cell death and apoptosis. A: Cell death induced by isomer <b>11</b> in combination with doxorubicin on MCF-7adr and SW480<sub>TR</sub> cells. B: Cell apoptosis induced by <b>11</b> in combination with doxorubicin on MCF-7adr and SW480<sub>TR</sub> cells. Cells were seeded at a density of 8000 cells per well in a 96-well plate for 24 h. The cells were then treated with <b>11</b>, doxorubicin, or a combination of the two drugs for an additional 48 h. The cells were lysed with 10% NP-40, and the M30-Apoptosense ELISA assay was performed as described in Materials and Methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Effect of Combination Therapy with <b>11</b> on Tumor Growth in Vivo</h3><div class="NLM_p">To further evaluate the effects of <b>11</b> and paclitaxel combination therapy on the tumor growth of resistant cells, the growth of xenograft tumors was examined. A well-characterized ovarian cancer MDR cell line, SKOV-3<sub>TR</sub>, was chosen for in vivo studies. The results showed that <b>11</b> or paclitaxel alone had no significant effects on the paclitaxel-resistant tumor cell growth in xenograft model. In contrast, the combination of paclitaxel and <b>11</b> produced an inhibitory effect on the resistant tumor growth as compared with animals treated with paclitaxel alone (20 mg/kg, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Intraperitoneal (ip) injection of <b>11</b>(50 mg/kg) was found to almost completely reverse resistance to paclitaxel in this model. In addition, on the basis of animal weight and mortality, no significant toxicity was observed and the animals appeared to have tolerated it well when <b>11</b> was administered alone.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of combination treatment with <b>11</b> and paclitaxel on tumor growth in vivo. A: Tumors were measured twice a week with a digital caliper. Tumor volume (mm<sup>3</sup>) was calculated as (<i>W</i><sup>2</sup> × <i>L</i>)/2, where <i>W</i> is width and <i>L</i> is length. B: Representative images of dissected tumor tissues from treated nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>5</b> is a newly identified small molecular compound found to efficiently reverse MDR in a wide variety of MDR cell lines.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The present studies were undertaken to synthesize <b>5</b> isomers <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b> based on its molecular chirality and to characterize these novel isomers in vitro and in vivo. We observe that <b>11</b> is a selective and very potent inhibitor of Pgp-mediated MDR, and the data provide valuable clues for the further optimization of this structure. The in vitro potency was evaluated by several assays (including cytotoxic drug activity by MTT assay, enhancement of drug uptake by calcein AM assay, and increased drug-induced apoptosis by M-13 apoptosense assay) using a panel of human MDR cell lines with different expressions of Pgp, MRP1, and BCRP. Not surprisingly, we observe that <b>11</b> recapitulates the activity of the diasteromeric mixture of <b>5</b> isomers; <b>11</b> reverses MDR in (Pgp) overexpressing cell lines for several chemotherapy drugs, is a highly potent, specific, nontoxic Pgp inhibitor, and does not inhibit MRP1 or BCRP1 at therapeutically relevant doses. <b>11</b> appears to possess all of the desired properties for treating Pgp-mediated MDR.</div><div class="NLM_p">Direct comparison with <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b> shows that <b>11</b> is the most potent modulator (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Previous and current studies have clearly indicated that reversal of MDR by <b>5</b> and its isomer <b>11</b> was through selective and potent inhibition of Pgp function.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For example, in contrast to reversing MDR in Pgp-overexpressed cell lines, <b>11</b> had no effect on drug sensitivities in MRP1- or BCRP-overexpressed MDR cell lines, nor did it affect the sensitivities to cisplatin or carboplatin (data not shown).</div><div class="NLM_p">In this study, we show new in vivo data confirming in mouse xenografts the expected activities seen in vitro. <b>11</b> exhibited potent activity after ip administration in mice bearing MDR human xenografts, restoring antitumor activity of paclitaxel without an apparent increase in toxicity. All of the efficacious combination schedules with <b>11</b> appeared to be well tolerated, as indicated by the lack of significant changes in body weights of various treatment groups. These results demonstrate that the <b>5</b> isomer <b>11</b> is an extremely potent, selective, and effective inhibitor of Pgp with a long duration of action. It exhibits potent activity without apparently enhancing the toxicity of coadministrated drugs.</div><div class="NLM_p last">In conclusion, <b>11</b> is a potent in vitro and in vivo modulator of MDR1 (Pgp)-mediated MDR. The properties of <b>11</b> indicate that it will be useful in the treatment of Pgp-mediated chemoresistant cancers.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedures for the Synthesis of <b>5</b> Isomers</h3><div class="NLM_p last">All evaporations were carried out in vacuo with a rotary evaporator. Analytical samples were dried in vacuo (1–5 mmHg) at room temperature. Thin layer chromatography (TLC) was performed on silica gel plates with fluorescent indicator. Spots were visualized by UV light (214 and 254 nm). Purification by column and flash chromatography was carried out using silica gel (300–400 mesh). Solvent systems are reported as volume percent mixture. All NMR spectra were recorded on a Bruker WH-300 (300 MHz) spectrometer. <sup>1</sup>H chemical shifts are reported in δ values in ppm with the deuterated solvent as the internal standard. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constant (Hz), integration. LCMS spectra were obtained on an Agilent 1200 series 6110 or 6120 mass spectrometer with electrospray ionization. LCMS: Method 1 (5-100a and 5-100b) = (Waters X Bridge C18, 50 mm × 4.6 mm × 3.5 μm, 2.3 min gradient, 5% [0.05% TFA/CH<sub>3</sub>CN]: 95% [0.05% TFA/H<sub>2</sub>O] to 100% [0.05% TFA/CH<sub>3</sub>CN] for 1.6 min and hold 100% [0.05% TFA/CH<sub>3</sub>CN] for 0.7 min; method 2 (5-100a (test) and 5-100b (test)) = (Waters X Bridge C18, 50 mm × 4.6 mm × 3.5 μm, 3.5 min gradient, 5% [0.05% TFA/CH<sub>3</sub>CN]: 95% [0.05% TFA/H<sub>2</sub>O] to 100% [0.05% TFA/CH<sub>3</sub>CN] for 1.6 min and hold 100% [0.05% TFA/CH<sub>3</sub>CN] for 1.9 min; method 3 (5–100A 5) = (Waters X Bridge C18, 50 mm × 4.6 mm × 3.5 μm, 5.8 min gradient, 5% [0.05% TFA/CH<sub>3</sub>CN]: 95% [0.05% TFA/H<sub>2</sub>O] to 100% [0.05% TFA/CH<sub>3</sub>CN] for 5.0 min and hold 100% [0.05% TFA/CH<sub>3</sub>CN] for 0.8 min. Preparative chiral HPLC purification was performed on a Shimadzu LC 20 with UV detector SPD-20A at 35 °C using CHIRALPAK IA (0.46 cm I.D. × 25 cm length) and using hexane/ispropanol/DEA = 70/30/0.1 (V/V/V) as the mobile phase. Flow rate was 1.0 mL/min (all solvents were HPLC grade). The HPLC system was monitored at 254 nm. Analytical chiral HPLC spectra were run on a Shimadzu LC 20 with UV detector SPD-20A at 35 °C using Chiralpak AD-H (0.46 × 25 cm) and using hexane/ispropanol/DEA = 70/30/0.1 (V/V/V) during 20 min as the mobile phase. Flow rate was 1.0 mL/min (all solvents were HPLC grade). The HPLC system was monitored at 254 nm. Optical rotation was run on a Polarimeter Perkin-Elmer Model 341 at 20 °C.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-(4-Methoxyphenyl)quinoline-4-carboxylic Acid (<b>1</b>)</h3><div class="NLM_p last">Indoline-2,3-dione (30.6 g, 203.9 mmol), 1-(4-methoxyphenyl)ethanone (25.0 g, 169.9 mmol), and KOH (28.6 g, 509.7 mmol) were dissolved in EtOH (200 mL). The mixture was stirred at 80 °C for 24 h. Evaporation of the solvent afforded a residue which was diluted in water, and then the solution was extracted by ether. The aqueous phase was acidified at 0 °C to pH = 1 with concd HCl, and then the precipitate was collected by suction filtration, washed with water and CH<sub>2</sub>Cl<sub>2</sub>, and dried in vacuo to afford 28.4 g (50% yield) of analytically pure <b>1</b> (yellow solid) confirmed by LCMS. Analytical LCMS (method 1): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.65 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 279.09 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Methyl 2-(4-Methoxyphenyl)quinoline-4-carboxylate (<b>2</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (15 g, 53.8 mmol) in MeOH (50 mL) was added concd H<sub>2</sub>SO<sub>4</sub> (13 mL). The mixture was stirred under reflux overnight, diluted by water, and extracted by AcOEt. The organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated under reduced pressure to afford 11.1 g (70%) of analytically pure <b>2</b> (yellow solid) confirmed by LCMS. Analytical LCMS (method 2): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 2.05 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 293.11 (M + H)<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (2-(4-Methoxyphenyl)quinolin-4-yl)(pyridin-2-yl)methanone (<b>3</b>)</h3><div class="NLM_p last">To a solution of n-BuLi (2.5 M, 26.4 mL, 66.1 mmol) in Et<sub>2</sub>O (80 mL) cooled to −40 °C under N<sub>2</sub> was added a solution of 2-bromopyridine (10.4 g, 66.1 mmol) in Et<sub>2</sub>O (20 mL). The reaction was maintained at −78 °C for 20 min, and then a solution of <b>2</b> (6.5 g, 22.0 mmol) in THF was added at −70 °C under N<sub>2</sub>. The reaction mixture was stirred at −70 °C for 1.5 h, quenched with water, and extracted by AcOEt. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo to give a residue. The residue was triturated with Et<sub>2</sub>O to afford 7 g (91%) of analytically pure <b>3</b> (yellow solid) confirmed by LCMS. Analytical LCMS (method 1): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.87 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 341.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (2-(4-Methoxyphenyl)quinolin-4-yl)(pyridin-2-yl)methanol (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>3</b> (7.7 g, 22.6 mmol) in EtOH (110 mL) cooled to 0 °C was added NaBH<sub>4</sub> (2.12 g, 45.3 mmol). After the addition was complete, the mixture was stirred for 0.5 h and then quenched with water. Then AcOEt was added to the solution, and the organic layer was separated, washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo to afford 4.6 g (60% yield) of <b>4</b> (white solid) which was used for the next step without further purification. Analytical LCMS (method 2): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.53 min, MS (ESI<sup>+</sup>) 343.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol (<b>5</b>) (NSC23925)</h3><div class="NLM_p last">To a solution of <b>4</b> (3.72 g, 10.88 mmol) in MeOH (360 mL) were added concd HCl (9 mL) and PtO<sub>2</sub> (741 mg, 3.26 mmol). The mixture was then hydrogenated at 20 °C for about 2 h. The catalyst was filtered off and washed with MeOH (3 × 10 mL), and the filtrate was concentrated under reduced pressure. The residue obtained was a dark green solid, which was used for the next step reaction without further purification. (We tried to directly separate the four isomers by using chiral prep HPLC but failed.) Analytical LCMS (method 2): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.28 min, MS (ESI<sup>+</sup>) 349.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>tert</i>-Butyl 2-(Hydroxy(2-(4-methoxyphenyl)quinolin-4-yl)methyl)piperidine-1-carboxylate (<b>6</b>, <b>7</b>)</h3><div class="NLM_p last">To a solution of <b>5</b> (the residue above) and Et<sub>3</sub>N (3.48 g, 34.48 mmol) in THF (50 mL) cooled at 0 °C was added a solution of (Boc)<sub>2</sub>O (4.0 g, 11.49 mmol) in THF (15 mL) dropwise. The mixture was stirred at r.t. overnight, and then water (50 mL) was added. The mixture was extracted with AcOEt (3 × 100 mL), and the combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo, and the crude residue was flash chromatographed on silica gel and eluted with 1:10–1:6 EA/PE to afford 1.0 g of <b>6</b> (threo isomer) (analytical LCMS (method 1): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.62 min, MS (ESI<sup>+</sup>) 449.0 (M + H)<sup>+</sup>) and 1.3 g of <b>7</b> (erythro isomer) (analytical LCMS (method 1): single peak (214, 254 nm), <i>t</i><sub>R</sub> = 1.68 min, MS (ESI<sup>+</sup>) 449.3 (M + H)<sup>+</sup>).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol Hydrochloride (<b>8</b>–<b>11</b>)</h3><div class="NLM_p last">After purification of <b>7</b> (1.3 g) by chiral HPLC, two Boc-protected chiral compounds were separated from each other. Then each compound was deprotected with a solution of HCl in EtOH to give the corresponding HCl salt. Thus, <b>10</b> (0.6 g) and <b>11</b> (0.6 g) were obtained, respectively. Using the same methods, <b>8</b> (0.37 g) and <b>9</b> (0.26 g) were produced, respectively, from 1 g of <b>6</b>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>R</i>,2<i>R</i>)-(2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol Hydrochloride (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35 (m, 2H), 1.72 (m, 4H), 2.81 (m, 1H), 3.24 (m, 1H), 3.49 (m, 1H), 3.89 (s, 3H), 4.5 (brs, 1H), 5.68 (s, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 7.74 (m, 1H), 7.93 (m, 1H), 8.26–8.38 (m, 5H), 8.53 (m, 1H), 9.25 (m, 1H); analytical LCMS (method 3): 97% purity (214 nm), <i>t</i><sub>R</sub> = 1.77 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 349.0 (M + H)<sup>+</sup>; [α]<sub>D</sub><sup>20</sup> = −15.3 (<i>c</i> = 0.16, MeOH); chiral HPLC purity: 99.9% ee (254 nm) (<i>t</i><sub>R</sub> (major) = 6.52 min, <i>t</i><sub>R</sub> (minor) = 8.69 min).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (1<i>S</i>,2<i>S</i>)-(2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol Hydrochloride (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35 (m, 2H), 1.72 (m, 4H), 2.81 (m, 1H), 3.24 (m, 1H), 3.49 (m, 1H), 3.89 (s, 3H), 4.5 (brs, 1H), 5.68 (s, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 7.74 (m, 1H), 7.93 (m, 1H), 8.26–8.38 (m, 5H), 8.53 (m, 1H), 9.25 (m, 1H); analytical LCMS (method 3): 99% purity (214 nm), <i>t</i><sub>R</sub> = 1.78 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 349.0 (M + H)<sup>+</sup>; [α]<sub>D</sub><sup>20</sup> = +15.0 (<i>c</i> = 0.16, MeOH); chiral HPLC purity: 99.9% ee (254 nm) (<i>t</i><sub>R</sub> (major) = 8.70 min, <i>t</i><sub>R</sub> (minor) = 6.53 min).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (1<i>R</i>,2<i>S</i>)-(2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol Hydrochloride (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.29 (m, 2H), 1.68 (m, 4H), 2.97 (m, 1H), 3.25 (m, 1H), 3.45 (m, 1H), 3.90 (s, 3H), 4.6 (brs, 1H), 6.11 (s, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 2H), 7.78 (m, 1H), 8.01 (m, 1H), 8.26 (m, 3H), 8.50 (m, 2H), 8.69 (t, <i>J</i> = 8.7 Hz, 1H), 10.46 (m, 1H); analytical LCMS (method 3): 95% purity (214 nm), <i>t</i><sub>R</sub> = 1.83 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 349.0 (M + H)<sup>+</sup>; [α]<sub>D</sub><sup>20</sup> = −15.8 (<i>c</i> = 0.2, MeOH); chiral HPLC purity: 99.9% ee (254 nm) (<i>t</i><sub>R</sub> (major) = 4.96 min, <i>t</i><sub>R</sub> (minor) = 12.7 min).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1<i>S</i>,2<i>R</i>)-(2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol Hydrochloride (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ1.29 (m, 2H), 1.68 (m, 4H), 2.97 (m, 1H), 3.25 (m, 1H), 3.45 (m, 1H), 3.90 (s, 3H), 4.6 (brs, 1H), 6.11 (s, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 2H), 7.78 (m, 1H), 8.01 (m, 1H), 8.26 (m, 3H), 8.50 (m, 2H), 8.69 (t, <i>J</i> = 8.7 Hz, 1H), 10.46 (m, 1H); analytical LCMS (method 3): 98% purity (214 nm), <i>t</i><sub>R</sub> = 1.83 min, MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 349.0 (M + H)<sup>+</sup>; [α]<sub>D</sub><sup>20</sup> = +15.6 (<i>c</i> = 0.2, MeOH); chiral HPLC purity: 97.2% ee (254 nm) (<i>t</i><sub>R</sub> (major) = 12.7 min, <i>t</i><sub>R</sub> (minor) = 4.7 min).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> X-ray Crystallography of <b>5</b> Isomers</h3><div class="NLM_p last">The absolute configuration of the isomer was determined by X-ray crystallography technique at the Center for Crystallographic Studies at Department of Chemistry and Chemical Biology, Harvard University. A crystal of a <b>5</b> isomer was mounted on a diffractometer, and data were collected at 100 K. The intensities of the reflections were collected by means of a Bruker APEX II CCD diffractometer (Mo<sub>Kα</sub> radiation, λ = 0.71073 Å) and equipped with an Oxford Cryosystems nitrogen flow apparatus. The collection method involved 0.5° scans in ω at 28° in 2θ. Data integration down to 0.76 Å resolution was carried out using SAINT V7.46 A with reflection spot size optimization. Absorption corrections were made with the program SADABS. The structure was solved by the direct methods procedure and refined by least-squares methods again <i>F</i><sup>2</sup> using SHELXS-97 and SHELXL-97. Non-hydrogen atoms were refined anisotropically, and hydrogen atoms were allowed to ride on the respective atoms. Crystal data, hydrogen bond parameters, and geometric parameters of the isomer were collected. The Ortep plots produced with the SHELXL-97 program, and the other drawings, were produced with Accelrys DS Visualizer 2.0.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Pharmacology, Cell Lines, Cell Culture, and Drugs</h3><div class="NLM_p last">A panel of a parental cancer cell line and their daughter resistant cell lines, displaying a MDR phenotype, were used in this study. Human ovarian cancer cell line SKOV-3, breast cancer cell line MCF-7, colon cancer cell line SW480, osteosarcoma cell line U-2OS, KHOS, uterine sarcoma cell line MESSA and its doxorubicin selected drug-resistant cell line MESSA/Dx5, and nonsmall cell lung cancer cell line H-69 and it is doxorubicin-selected drug-resistant cell line H-69AR (overexpresses MRP1) were obtained from the ATCC (Rockville, MD). The multidrug-resistant SKOV-3<sub>TR</sub>, MCF-7adr, and SW480<sub>TR</sub> cell lines were established as previously reported. Dr. Efstathios Gonos (Institute of Biological Research & Biotechnology, Athens, Greece) provided the doxorubicin-resistant U-2OS R2 (referred in the text below as U-2OS<sub>DR</sub>), KHOS R2 cell lines. Dr. Erasmus Schneider (Wadsworth Center, Albany) provided the mitoxantrone-resistant breast cancer MCF-7/MX (overexpresses BCRP) cell line. All the cell lines were cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL streptomycin (Invitrogen). Cells were incubated at 37 °C in 5% CO<sub>2</sub>–95% air atmosphere and passaged when near-confluent monolayers were achieved using 2% trypsin–EDTA solution. Drug-resistant cell lines were periodically cultured in the respective drug to confirm their drug resistance characteristics. The chemotherapy drugs were obtained from the pharmacy at the Massachusetts General Hospital and stored at −20 °C.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cytotoxicity MTT Assay and Reversals of MDR</h3><div class="NLM_p last">To evaluate for reversal of Pgp-mediated MDR, SKOV-3<sub>TR</sub>, MCF-7adr, and SW480<sub>TR</sub> cell lines were seeded into a 96-well tissue culture plate at 2000 cells per well with varying concentrations of chemotherapy drugs and <b>11</b> for 6 days. Cell proliferation IC<sub>50</sub> (concentration required for 50% inhibition) and MDR reversal IC<sub>50</sub> were determined from dose–response curves carried out in triplate in a 96-well plate. The fold of reverse resistance for individual drugs were defined as the IC<sub>50</sub> of MDR cells without <b>11</b> treatment divided by the IC<sub>50</sub> of MDR cells treated with <b>11</b>. To test for the effect of reversal of MRP1- or BCRP-mediated MDR, H-69AR or MCF-7/MX cells were placed into 96-well plates and treated with chemotherapy drugs similar to that described above. Drug cytotoxicity was assessed in vitro using the MTT assay as previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Drugs at the concentrations utilized in the MTT assay were performed in the absence of cells to verify no change in absorbances. Response curves were fitted with the use of GraphPad PRISM 4 software (GraphPad Software).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Drug Efflux Fluorescence Microscopy Assay</h3><div class="NLM_p last">The Vybrant multidrug resistance assay kit (Invitrogen/Molecular Probes) was used to measure drug efflux properties of different resistant cell lines. This assay utilizes the fluorogenic dye calcein acetoxymethyl ester (calcein AM) as a substrate for efflux activity of Pgp or other membrane pump ABC proteins. Calcein AM is taken up by cells and hydrolyzed by cytoplasmic esterases to fluorescent calcein. Calcein AM is well retained in the cytosol. However, multidrug-resistant cells expressing high levels of Pgp rapidly extrude nonfluorescent calcein AM from the plasma membrane, reducing accumulation of fluorescent calcein in the cytosol. Studies were carried out as described. In brief, drug-resistant cells (5000 cells per well) were cultured in a 96-well plate for 24 h. Triplicated cultures of cells were treated with different concentrations of <b>11</b> for 1 h and then incubated in calcein AM in 100 μL of total volume. After 30 min, images were acquired by Nikon Eclipse Ti-U fluorescence microscope (Nikon Corp.) equipped with a SPOT RT digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Apoptosis Assays</h3><div class="NLM_p last">Apoptosis was evaluated using the M30-Apoptosense ELISA assay kit (Peviva AB, Bromma, Sweden) according to the manufacturer’s instructions. For the doxorubicin and <b>11</b> treatment, MCF-7adr or SW480<sub>TR</sub> cells were seeded at 8000 cells/per well in a 96-well plate for 24 h before treatment. The cells were then treated with 0.5 μM doxorubicin, 1 μM <b>11</b>, or a combination of the two drugs for an additional 72 h. The cells were then lysed by an additional 10 μL of 10% NP40 per well, following the manufacturer’s instructions for apoptosis assay.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Effect of Combination 11 and Paclitaxel on Tumor Growth in Vivo</h3><div class="NLM_p last">The Crl:SHO-<i>Prkdc</i><sup>SCID</sup><i>Hr</i><sup><i>hr</i></sup> nude female mice at approximately 3–4 weeks of age were purchased from The Charles River Laboratories (Ann Arbor, MI). Animal studies were carried out with protocols approved by the Massachusetts General Hospital Subcommittee on Research Animal Care (SRAC). To determine the effect of <b>11</b> on paclitaxel sensitivity in the xenograft model, 5 × 10<sup>6</sup> SKOV-3 <sub>TR</sub> cells were injected subcutaneously with matrigel (BD Biosciences, San Jose, CA) on day one. Two weeks after injection, the mice were divided into four groups to start the treatments. Group one received intraperitoneal (ip) injection with normal saline, group two with paclitaxel (20 mg/kg), and group three with <b>11</b> (50 mg/kg). The final group of mice received paclitaxel (20 mg/kg) and <b>11</b> (50 mg/kg). The dose of paclitaxel (20 mg/kg) was based on previous studies.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> All four groups were treated twice a week for two weeks. The health of the mice and evidence of tumor growth were examined daily. Tumors were measured twice a week with a digital caliper. Tumor volume (mm<sup>3</sup>) was calculated as (<i>W</i><sup>2</sup> × <i>L</i>)/2, where <i>W</i> is width and <i>L</i> is length. The curve of tumor growth was drawn according to tumor volume by using of GraphPad PRISM 4 software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/jm300117u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Perspective views showing 50% probability displacement ellipsoids of absolute configuration for all four isomers (Figure 1). Chiral HPLC spectra of four compounds <b>8</b>, <b>9</b>, <b>10</b> and <b>11</b> (Figure 2). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300117u/suppl_file/jm300117u_si_001.pdf">jm300117u_si_001.pdf (144.24 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300117u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenfeng Duan</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f4e5f1feead0f8f5fcf9e8befdf7f8bef8f1e2e6f1e2f4bef5f4e5"><span class="__cf_email__" data-cfemail="86e2f3e7e8fcc6eee3eaeffea8ebe1eea8eee7f4f0e7f4e2a8e3e2f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Li</span> - <span class="hlFld-Affiliation affiliation">Chengdu
ChemPartner
Co., Ltd., Floor 3, Building 3, Tianfu Life Science
Park, No. 88, Keyuan South Road, Hi-Tech Zone, Chengdu, 610041, People's
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haoxi Huang</span> - <span class="hlFld-Affiliation affiliation">Chengdu
ChemPartner
Co., Ltd., Floor 3, Building 3, Tianfu Life Science
Park, No. 88, Keyuan South Road, Hi-Tech Zone, Chengdu, 610041, People's
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Yuan</span> - <span class="hlFld-Affiliation affiliation">Chengdu
ChemPartner
Co., Ltd., Floor 3, Building 3, Tianfu Life Science
Park, No. 88, Keyuan South Road, Hi-Tech Zone, Chengdu, 610041, People's
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shao-Liang Zheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and
Chemical Biology, Harvard University, Cambridge,
Massachusetts 02138, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianzhe Liu</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhan Zhang</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">The Third Affiliated
Hospital of Zhengzhou University, People's Republic
of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwin Choy</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Harmon</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry Mankin</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francis Hornicek</span> - <span class="hlFld-Affiliation affiliation">Sarcoma Biology Laboratory, Center
for Sarcoma and Connective Tissue Oncology, Massachusetts
General Hospital, Boston, Massachusetts 02114, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d305e1905-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by grants from the Gattegno and Wechsler funds. Support has also been provided by the Kenneth Stanton Fund. Dr. Duan is supported, in part, through a grant from Sarcoma Foundation of America (SFA), a grant from National Cancer Institute (NCI)/National Institutes of Health (NIH), UO1, CA 151452.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> Abbreviations Used</h2><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">MRP1</td><td class="NLM_def"><p class="first last">multidrug-resistant protein 1</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer-resistant protein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1038%2Fnrd1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=16518375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance in cancer</span></div><div class="casAuthors">Szakacs, Gergely; Paterson, Jill K.; Ludwig, Joseph A.; Booth-Genthe, Catherine; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-234</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy.  In most cases, multiple drugs are used, as resistance to single agents occurs almost universally.  For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chem. structures - multidrug resistance - has been a major goal of cancer biologists during the past 35 years.  Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.  We describe various approaches to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LUp3JikHr7Vg90H21EOLACvtfcHk0lij2YiqH_6DnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D&md5=67ca376f65aa58a71288167f6815a896</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1984%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gillet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F138920111795163931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21118086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Ohsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=686-692&author=J.+P.+Gilletauthor=M.+M.+Gottesman&title=Advances+in+the+molecular+detection+of+ABC+transporters+involved+in+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer</span></div><div class="casAuthors">Gillet, Jean-Pierre; Gottesmann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">686-692</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-Binding Cassette (ABC) transporters are important mediators of multidrug resistance (MDR) in patients with cancer.  Although their role in MDR has been extensively studied in vitro, their value in predicting response to chemotherapy has yet to be fully detd.  Establishing a mol. diagnostic assay dedicated to the quantitation of ABC transporter genes is therefore crit. to investigate their involvement in clin. MDR.  In this article, we provide an overview of the methodologies that have been applied to analyze the mRNA expression levels of ABC transporters, by describing the technol., its pros and cons, and the exptl. protocols that have been followed.  We also discuss recent studies performed in our lab. that assess the ability of the currently available high-throughput gene expression profiling platforms to discriminate between highly homologous genes.  This work led to the conclusion that high-throughput TaqMan-based qRT-PCR platforms provide standardized clin. assays for the mol. detection of ABC transporters and other families of highly homologous MDR-linked genes encoding, for example, the uptake transporters (solute carriers-SLCs) and the phase I and II metab. enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxc4ollS9ZQbVg90H21EOLACvtfcHk0lij2YiqH_6DnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Ohsbw%253D&md5=bd4eddd90da2c343d61dbecec991621d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138920111795163931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920111795163931%26sid%3Dliteratum%253Aachs%26aulast%3DGillet%26aufirst%3DJ.%2BP.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DAdvances%2520in%2520the%2520molecular%2520detection%2520of%2520ABC%2520transporters%2520involved%2520in%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2011%26volume%3D12%26spage%3D686%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yusuf, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamendola, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiden, M. V.</span><span> </span><span class="NLM_article-title">Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F1568009033333754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=12570657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1-19&author=R.+Z.+Yusufauthor=Z.+Duanauthor=D.+E.+Lamendolaauthor=R.+T.+Pensonauthor=M.+V.+Seiden&title=Paclitaxel+resistance%3A+molecular+mechanisms+and+pharmacologic+manipulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation</span></div><div class="casAuthors">Yusuf, R. Z.; Duan, Z.; Lamendola, D. E.; Penson, R. T.; Seiden, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been approx. ten years since the Food and Drug Administration (FDA) approved paclitaxel for the treatment of platinum resistant epithelial ovarian carcinoma.  Since the approval, the drug has found therapeutic applications in a variety of schedules and in a wide variety of epithelial malignancies.  Its novel mechanism of action provided the hope that it would demonstrate anti-neoplastic activity in multidrug resistant tumor cells.  Unfortunately, as with other chemotherapeutic drugs, resistance is commonly seen.  Lab. investigation has defined a wide variety of resistance mechanisms including overexpression of multidrug resistance (MDR-1) gene, mol. changes in the target mol. (β-tubulin), changes in apoptotic regulatory and mitosis checkpoint proteins, and more recently changes in lipid compn. and potentially the overexpression of interleukin 6 (IL-6).  This review describes the in vitro mol. data that define and support the various mechanisms of resistance and critically evaluates the evidence for the participation of these mechanisms in clin. relevant paclitaxel resistance.  This review also explores pharmacol. attempts to modulate paclitaxel resistance, principally through inhibition of the MDR-1 drug efflux pump.  Future avenues for drug resistance research and its pharmacol. manipulation in the clinic are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozwrhfHI8_-7Vg90H21EOLACvtfcHk0lhv9e5FHpKUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVGntg%253D%253D&md5=6f173a1a569fa11e38b9ddb2af239aca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568009033333754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033333754%26sid%3Dliteratum%253Aachs%26aulast%3DYusuf%26aufirst%3DR.%2BZ.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DLamendola%26aufirst%3DD.%2BE.%26aulast%3DPenson%26aufirst%3DR.%2BT.%26aulast%3DSeiden%26aufirst%3DM.%2BV.%26atitle%3DPaclitaxel%2520resistance%253A%2520molecular%2520mechanisms%2520and%2520pharmacologic%2520manipulation%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lhv9e5FHpKUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Duan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F. J.</span><span> </span><span class="NLM_article-title">NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7415&author=Z.+Duanauthor=E.+Choyauthor=F.+J.+Hornicek&title=NSC23925%2C+identified+in+a+high-throughput+cell-based+screen%2C+reverses+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DHornicek%26aufirst%3DF.%2BJ.%26atitle%3DNSC23925%252C%2520identified%2520in%2520a%2520high-throughput%2520cell-based%2520screen%252C%2520reverses%2520multidrug%2520resistance%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Conseil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P.</span><span> </span><span class="NLM_article-title">Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters</span> <span class="citation_source-journal">Pharmacogenet. Genom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1097%2F01.fpc.0000167333.38528.ec" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=16006996" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=523-533&author=G.+Conseilauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Polymorphisms+of+MRP1+%28ABCC1%29+and+related+ATP-dependent+drug+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F01.fpc.0000167333.38528.ec&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.fpc.0000167333.38528.ec%26sid%3Dliteratum%253Aachs%26aulast%3DConseil%26aufirst%3DG.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DPolymorphisms%2520of%2520MRP1%2520%2528ABCC1%2529%2520and%2520related%2520ATP-dependent%2520drug%2520transporters%26jtitle%3DPharmacogenet.%2520Genom.%26date%3D2005%26volume%3D15%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The challenge of exploiting ABCG2 in the clinic</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F138920111795163913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21118093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1OhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=595-608&author=R.+W.+Robeyauthor=C.+Ieranoauthor=Z.+Zhanauthor=S.+E.+Bates&title=The+challenge+of+exploiting+ABCG2+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of exploiting ABCG2 in the clinic</span></div><div class="casAuthors">Robey, Robert W.; Ierano, Caterina; Zhan, Zhirong; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ABCG2, or breast cancer resistance protein (BCRP), is an ATP-binding cassette half transporter that has been shown to transport a wide range of substrates including chemotherapeutics, antivirals, antibiotics and flavonoids.  Given its wide range of substrates, much work has been dedicated to developing ABCG2 as a clin. target.  But where can we intervene clin. and how can we avoid the mistakes made in past clin. trials targeting P-glycoprotein.  This review will summarize the normal tissue distribution, cancer tissue expression, substrates and inhibitors of ABCG2, and highlight the challenges presented in exploiting ABCG2 in the clinic.  We discuss the possibility of inhibiting ABCG2, so as to increase oral bioavailability or increase drug penetration into sanctuary sites, esp. the central nervous system; and at the other end of the spectrum, the possibility of improving ABCG2 function, in the case of gout caused by a single nucleotide polymphism.  Together, these aspects of ABCG2/BCRP make the protein a target of continuing interest for oncologists, biologists, and pharmacologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSJ3cQu16BLVg90H21EOLACvtfcHk0lhv9e5FHpKUKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1OhsLs%253D&md5=4da2cfd21a7c63f6b7cb357645394d4b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F138920111795163913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920111795163913%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520challenge%2520of%2520exploiting%2520ABCG2%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2011%26volume%3D12%26spage%3D595%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">Strategies for reversing drug resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7512-7523&author=T.+Fojoauthor=S.+Bates&title=Strategies+for+reversing+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DStrategies%2520for%2520reversing%2520drug%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7512%26epage%3D7523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Morjani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madoulet, C.</span><span> </span><span class="NLM_article-title">Immunosuppressors as multidrug resistance reversal agents</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">596</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1007%2F978-1-60761-416-6_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=19949935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=596&publication_year=2010&pages=433-446&author=H.+Morjaniauthor=C.+Madoulet&title=Immunosuppressors+as+multidrug+resistance+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressors as multidrug resistance reversal agents</span></div><div class="casAuthors">Morjani, Hamid; Madoulet, Claudie</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">596</span>
        (<span class="NLM_cas:issue">Multi-Drug Resistance in Cancer</span>),
    <span class="NLM_cas:pages">433-446</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Multidrug-resistance (MDR) is the major reason for failure of cancer therapy.  ATP-binding cassette (ABC) transporters contribute to drug resistance via ATP-dependent drug efflux.  P-glycoprotein (Pgp), which is encoded by MDR1 gene, confers resistance to certain anticancer agents.  The development of agents able to modulate MDR mediated by Pgp and other ABC transporters remained a major goal for the past 20 years.  The calcium blocker verapamil was the first drug shown to be a modulator of Pgp, and since many different chem. compds. have been shown to exert the same effect in vitro by blocking Pgp activity.  These included particularly immunosuppressors.  Cyclosporin A (CSA) was the first immunosuppressor that have been shown to modulate Pgp activity in lab. models and entered very early into clin. trials for reversal of MDR.  The proof of reversing activity of CSA was found in phase II studies with myeloma and acute leukemia.  In phase III studies, the results were less convincing regarding the response rate, progression-free survival, and overall survival, which were detected in advanced refractory myeloma.  The non-immunosuppressive deriv. PSC833 (valspodar) was subsequently developed.  This compd. showed tenfold higher potency in reversal of MDR mediated by Pgp.  However, pharmacokinetic interactions required redns. in the dose of the concurrently administered anticancer agents.  The pharmacokinetic interactions were likely because of decreased clearance of the anticancer agents, possibly as a result of Pgp inhibition in organs such as the gastrointestinal tract and kidney, as well as inhibition of cytochrome P 450.  Finally, CSA and PSC833 have been shown also to modulate the ceramide metab. which stands as second messenger of anticancer agent-induced apoptosis.  In fact, CSA and PSC833 are also able to resp. inhibit ceramide glycosylation and stimulate de novo ceramide synthesis.  This could enhance the cellular level of ceramide and potentiate apoptosis induced by some anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrek9xZV-6xrrVg90H21EOLACvtfcHk0ljmwCwf6Sn-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKhurs%253D&md5=197eccb0bb61c8b9424e45ab87dc3b1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-416-6_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-416-6_19%26sid%3Dliteratum%253Aachs%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DMadoulet%26aufirst%3DC.%26atitle%3DImmunosuppressors%2520as%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D596%26spage%3D433%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tamaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The controversial role of ABC transporters in clinical oncology</span> <span class="citation_source-journal">Essays Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1042%2Fbse0500209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21967059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGrsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=209-232&author=A.+Tamakiauthor=C.+Ieranoauthor=G.+Szakacsauthor=R.+W.+Robeyauthor=S.+E.+Bates&title=The+controversial+role+of+ABC+transporters+in+clinical+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The controversial role of ABC transporters in clinical oncology</span></div><div class="casAuthors">Tamaki, Akina; Ierano, Caterina; Szakacs, Gergely; Robey, Robert W.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Essays in Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-232</span>CODEN:
                <span class="NLM_cas:coden">ESBIAV</span>;
        ISSN:<span class="NLM_cas:issn">0071-1365</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The phenomenon of multidrug resistance in cancer is often assocd. with the overexpression of the ABC (ATP-binding cassette) transporters Pgp (P-glycoprotein) (ABCB1), MRP1 (multidrug resistance-assocd. protein 1) (ABCC1) and ABCG2 [BCRP (breast cancer resistance protein)].  Since the discovery of Pgp over 35 years ago, studies have convincingly linked ABC transporter expression to poor outcome in several cancer types, leading to the development of transporter inhibitors.  Three generations of inhibitors later, we are still no closer to validating the 'Pgp hypothesis', the idea that increased chemotherapy efficacy can be achieved by inhibition of transporter-mediated efflux.  In this chapter, we highlight the difficulties and past failures encountered in the development of clin. inhibitors of ABC transporters.  We discuss the challenges that remain in our effort to exploit decades of work on ABC transporters in oncol.  In learning from past mistakes, it is hoped that ABC transporters can be developed as targets for clin. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTf-JsvF3tlLVg90H21EOLACvtfcHk0ljmwCwf6Sn-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGrsb7O&md5=3c63559612797c2339f046019985def9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2Fbse0500209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbse0500209%26sid%3Dliteratum%253Aachs%26aulast%3DTamaki%26aufirst%3DA.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520controversial%2520role%2520of%2520ABC%2520transporters%2520in%2520clinical%2520oncology%26jtitle%3DEssays%2520Biochem.%26date%3D2011%26volume%3D50%26spage%3D209%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span> </span><span class="NLM_article-title">Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1007%2Fs00280-003-0742-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=14666379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=349-356&author=L.+Fuauthor=Y.+Liangauthor=L.+Dengauthor=Y.+Dingauthor=L.+Chenauthor=Y.+Yeauthor=X.+Yangauthor=Q.+Pan&title=Characterization+of+tetrandrine%2C+a+potent+inhibitor+of+P-glycoprotein-mediated+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance</span></div><div class="casAuthors">Fu, Liwu; Liang, Yongju; Deng, Liwen; Ding, Yan; Chen, Liming; Ye, Yanli; Yang, Xiaoping; Pan, Qichao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is one of the main obstacles in tumor chemotherapy.  A promising approach to solving this problem is to utilize a nontoxic and potent modulator able to reverse MDR, which in combination with anticancer drugs increases the anticancer effect.  Expts. were carried out to examine the potential of tetrandrine (Tet) as a MDR-reversing agent.  Survival of cells incubated with Tet at 2.5 μmol/l for 72 h was over 90%.  Tet at 2.5 μmol/l almost completely reversed resistance to vincristine (VCR) in KBv200 cells.  Tet at a concn. as low as 0.625 μmol/l produced a 7.6-fold reversal of MDR, but showed no effect on the sensitivity of drug-sensitive KB cells in vitro.  In the KBv200 cell xenograft model in nude mice, neither Tet nor VCR inhibited tumor growth.  However, VCR and Tet combined inhibited tumor growth by 45.7%, 61.2% and 55.7% in three independent exptl. settings.  In the KB cell xenograft model in nude mice, Tet did not inhibit tumor growth, but VCR and the combination of VCR and Tet inhibited tumor growth by 40.6% and 41.6%, resp.  Mechanism studies showed that Tet inhibited [3H]azidopine photoaffinity labeling of P-gp and increased accumulation of VCR in MDR KBv200 cells in a concn.-dependent manner.  The results suggest that Tet is a potent MDR-reversing agent in vitro and in vivo.  Its mechanism of action is via directly binding to P-gp and increasing intracellular VCR accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0IG_UCsUo7Vg90H21EOLACvtfcHk0ljmwCwf6Sn-hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWhu7Y%253D&md5=3e1896069b4095527085849ba771405f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0742-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0742-5%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DQ.%26atitle%3DCharacterization%2520of%2520tetrandrine%252C%2520a%2520potent%2520inhibitor%2520of%2520P-glycoprotein-mediated%2520multidrug%2520resistance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span> </span><span class="NLM_article-title">A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=924-932&author=L.+Gandhiauthor=M.+W.+Hardingauthor=M.+Neubauerauthor=C.+J.+Langerauthor=M.+Mooreauthor=H.+J.+Rossauthor=B.+E.+Johnsonauthor=T.+J.+Lynch&title=A+phase+II+study+of+the+safety+and+efficacy+of+the+multidrug+resistance+inhibitor+VX-710+combined+with+doxorubicin+and+vincristine+in+patients+with+recurrent+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DNeubauer%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DC.%2BJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DRoss%26aufirst%3DH.%2BJ.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520the%2520safety%2520and%2520efficacy%2520of%2520the%2520multidrug%2520resistance%2520inhibitor%2520VX-710%2520combined%2520with%2520doxorubicin%2520and%2520vincristine%2520in%2520patients%2520with%2520recurrent%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%26date%3D2007%26volume%3D109%26spage%3D924%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Susa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span> </span><span class="NLM_article-title">Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1177%2F1087057109359422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=20150589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFWjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=287-296&author=M.+Susaauthor=E.+Choyauthor=C.+Yangauthor=J.+Schwabauthor=H.+Mankinauthor=F.+Hornicekauthor=Z.+Duan&title=Multidrug+resistance+reversal+agent%2C+NSC77037%2C+identified+with+a+cell-based+screening+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay</span></div><div class="casAuthors">Susa, Michiro; Choy, Edwin; Yang, Cao; Schwab, Joseph; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-296</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) remains a significant obstacle in treating cancer patients with chemotherapy.  To identify small-mol. compds. that can reverse MDR, the authors used a cell-based screening assay with an MDR ovarian cancer cell line.  Incubating MDR cells with a sublethal concn. of paclitaxel in combination with each of 2000 small-mol. compds. from the National Cancer Institute Diversity Set Library, they identified NSC77037.  The cytotoxic activity of NSC77037 and the duration of its effect were evaluated in vitro using a panel of cancer cell lines expressing permeability glycoprotein (Pgp), multiple drug resistance protein 1 (MRP 1), and breast cancer resistance protein (BCRP).  The mechanism of its effects was further analyzed by assessing the retention of calcein and Pgp-ATPase activity.  The relative potency of MDR reversal by NSC77037 was significantly higher than that of frequently used MDR reversal agents such as verapamil and cyclosporine A.  NSC77037 reversed Pgp without reversing MRP or BCRP-mediated MDR.  NSC77037, at a concn. of >10 μM, moderately inhibited the proliferation of both sensitive and resistant cell lines, but the inhibitory effect of NSC77037 was not altered by coincubation with the Pgp inhibitor verapamil, suggesting that NSC77037 itself is not a substrate of Pgp.  NSC77037 directly inhibited the function of Pgp in a dose-dependent manner, but it did not alter the protein expression level of Pgp.  The use of NSC77037 to restore sensitivity to chemotherapy or to prevent resistance could be a potential treatment strategy for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAessbKDM2oLVg90H21EOLACvtfcHk0lgWGya3Xr-UTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFWjsrY%253D&md5=96d4ecfb2baf6e180f0ec3add6bcb47e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1177%2F1087057109359422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109359422%26sid%3Dliteratum%253Aachs%26aulast%3DSusa%26aufirst%3DM.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSchwab%26aufirst%3DJ.%26aulast%3DMankin%26aufirst%3DH.%26aulast%3DHornicek%26aufirst%3DF.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DMultidrug%2520resistance%2520reversal%2520agent%252C%2520NSC77037%252C%2520identified%2520with%2520a%2520cell-based%2520screening%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2010%26volume%3D15%26spage%3D287%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mead, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senear, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepfli, J. B.</span><span> </span><span class="NLM_article-title">The synthesis of potential antimalarials; 2-alkyl-alpha-(2-piperidyl)-4-quinolinemethanols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2708</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01216a088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=2708-2710&author=J.+F.+Meadauthor=A.+E.+Senearauthor=J.+B.+Koepfli&title=The+synthesis+of+potential+antimalarials%3B+2-alkyl-alpha-%282-piperidyl%29-4-quinolinemethanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja01216a088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01216a088%26sid%3Dliteratum%253Aachs%26aulast%3DMead%26aufirst%3DJ.%2BF.%26aulast%3DSenear%26aufirst%3DA.%2BE.%26aulast%3DKoepfli%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520synthesis%2520of%2520potential%2520antimalarials%253B%25202-alkyl-alpha-%25282-piperidyl%2529-4-quinolinemethanols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D2708%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Carson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclay, W. D.</span><span> </span><span class="NLM_article-title">The acylation of polyuronides with formamide as a dispersing agent</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01210a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=1015-1027&author=J.+F.+Carsonauthor=W.+D.+Maclay&title=The+acylation+of+polyuronides+with+formamide+as+a+dispersing+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja01210a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01210a034%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DJ.%2BF.%26aulast%3DMaclay%26aufirst%3DW.%2BD.%26atitle%3DThe%2520acylation%2520of%2520polyuronides%2520with%2520formamide%2520as%2520a%2520dispersing%2520agent%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D1015%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nageshwar, Y. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshram, H. M.</span><span> </span><span class="NLM_article-title">A Facile and Alternative Method for the Synthesis of Mefloquine</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1080%2F00397919608003544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADyaK28XisVakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1913-1919&author=M.+S.+Kumarauthor=Y.+V.+D.+Nageshwarauthor=H.+M.+Meshram&title=A+Facile+and+Alternative+Method+for+the+Synthesis+of+Mefloquine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A facile and alternative method for the synthesis of mefloquine</span></div><div class="casAuthors">Kumar, M. Suresh; Nageshwar, Y. V. D.; Meshram, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1913-19</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A convenient and facile synthesis of Mefloquine, based on sulfoxide-Grignard approach is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWuXe2nlWrbVg90H21EOLACvtfcHk0lhkzC9uYlDtsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVakur4%253D&md5=d4807b64ffae4ab9bad41a1a5890b69a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397919608003544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919608003544%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%2BS.%26aulast%3DNageshwar%26aufirst%3DY.%2BV.%2BD.%26aulast%3DMeshram%26aufirst%3DH.%2BM.%26atitle%3DA%2520Facile%2520and%2520Alternative%2520Method%2520for%2520the%2520Synthesis%2520of%2520Mefloquine%26jtitle%3DSynth.%2520Commun.%26date%3D1996%26volume%3D26%26spage%3D1913%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Solladie-Cavallo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaakoub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azyat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suteu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nafie, L.</span><span> </span><span class="NLM_article-title">A. <i>erythro</i>-1-Naphthyl-1-(2-piperidyl)methanol: synthesis, resolution, NMR relative configuration, and VCD absolute configuration</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7308</span><span class="NLM_x">–</span> <span class="NLM_lpage">7315</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0345502" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7308-7315&author=A.+Solladie-Cavalloauthor=C.+Marsolauthor=M.+Yaakoubauthor=K.+Azyatauthor=A.+Kleinauthor=M.+Rojeauthor=C.+Suteuauthor=T.+B.+Freedmanauthor=X.+Caoauthor=L.+Nafie&title=A.+erythro-1-Naphthyl-1-%282-piperidyl%29methanol%3A+synthesis%2C+resolution%2C+NMR+relative+configuration%2C+and+VCD+absolute+configuration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo0345502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0345502%26sid%3Dliteratum%253Aachs%26aulast%3DSolladie-Cavallo%26aufirst%3DA.%26aulast%3DMarsol%26aufirst%3DC.%26aulast%3DYaakoub%26aufirst%3DM.%26aulast%3DAzyat%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DA.%26aulast%3DRoje%26aufirst%3DM.%26aulast%3DSuteu%26aufirst%3DC.%26aulast%3DFreedman%26aufirst%3DT.%2BB.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DNafie%26aufirst%3DL.%26atitle%3DA.%2520erythro-1-Naphthyl-1-%25282-piperidyl%2529methanol%253A%2520synthesis%252C%2520resolution%252C%2520NMR%2520relative%2520configuration%252C%2520and%2520VCD%2520absolute%2520configuration%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D7308%26epage%3D7315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gillespie, R. J.; Lerpiniere, J.; Giles, P. R.; Adams, D. R.; Knutsen, L. J. S.; Cliffe, I. A.</span><span> </span><span class="NLM_article-title">4-Quinolinemethanol derivatives as purine receptor antagonists (II). </span>U.S. Patent 6608085B1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+J.+Gillespie&author=J.+Lerpiniere&author=P.+R.+Giles&author=D.+R.+Adams&author=L.+J.+S.+Knutsen&author=I.+A.+Cliffe&title=4-Quinolinemethanol+derivatives+as+purine+receptor+antagonists+%28II%29.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26atitle%3D4-Quinolinemethanol%2520derivatives%2520as%2520purine%2520receptor%2520antagonists%2520%2528II%2529.%2520%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=3802100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetric+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a tetrazolium-based semiautomated colorimetric assay:  assessment of chemosensitivity testing</span></div><div class="casAuthors">Carmichael, James; DeGraff, William G.; Gazdar, Adi F.; Minna, John D.; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">936-42</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Drug sensitivity assays were performed using a variation of a colorimetric thiazolyl blue (MTT)  [298-93-1] assay on V79, CHO-AuxB1, CHRC5, NCI-H460, and NCI-H249 cell lines following optimization of exptl. conditions for each cell line.  Results from this assay were compared with data assimilated simultaneously by clonogenic assay and by dye exclusion assay.  Good correlation was obsd. using the CHO-AuxB1 cell line and the pleiotropic drug-resistant mutant CHRC5, with similar degrees of relative resistance obsd. with both the MTT and clonogenic assays.  Good correlation was obsd. between the clonogenic and MTT assays for 1-h drug exposures, although the MTT assay was more sensitive to vinblastine.  In general, the clonogenic assay was more sensitive when continuous drug exposures were utilized, although this was primarily related to the increased drug exposure time.  While the use of the MTT assay in drug sensitivity testing of primary tumor samples is limited, since contaminating normal cells may also reduce the tetrazolium, the MTT assay can be semiautomated, and therefore it offers a valid, simple method of assessing chemosensitivity in established cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj92XstI7WtLVg90H21EOLACvtfcHk0lhkzC9uYlDtsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D&md5=2414230269c9f4d5f2910764c65fc042</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetric%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, R. B.</span><span> </span><span class="NLM_article-title">Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1087-1092&author=L.+Huauthor=J.+Hofmannauthor=Y.+Luauthor=G.+B.+Millsauthor=R.+B.+Jaffe&title=Inhibition+of+phosphatidylinositol+3%E2%80%B2-kinase+increases+efficacy+of+paclitaxel+in+in+vitro+and+in+vivo+ovarian+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DJaffe%26aufirst%3DR.%2BB.%26atitle%3DInhibition%2520of%2520phosphatidylinositol%25203%25E2%2580%25B2-kinase%2520increases%2520efficacy%2520of%2520paclitaxel%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520ovarian%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1087%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaloudek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, R. B.</span><span> </span><span class="NLM_article-title">In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=10741711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=880-886&author=L.+Huauthor=C.+Zaloudekauthor=G.+B.+Millsauthor=J.+Grayauthor=R.+B.+Jaffe&title=In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)</span></div><div class="casAuthors">Hu, Limin; Zaloudek, Charles; Mills, Gordon B.; Gray, Joe; Jaffe, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-886</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase (PI3-K) induces mitogenesis, cell growth, and cell transformation.  Amplification of the gene encoding the P110α subunit likely is an important event in ovarian cancer progression, and PI3-K inhibitors are possible therapeutic agents for this disease.  We evaluated effects of LY294002, a potent inhibitor of PI3-K, on growth of ovarian carcinoma in vivo and in vitro, and on ascites formation in vivo.  Athymic mice were inoculated i.p. with the ovarian cancer cell line OVCAR-3.  Seven days after inoculation, mice were treated with or without LY294002 (100 mg/kg of body wt.) for 3 wk.  Body wt. and abdominal circumference were measured twice weekly.  At the end of the expt., mice were sacrificed, ascites vol. was measured, and tumors were excised.  Mean tumor burden in the LY294002-treated group was reduced by ∼65% vs. controls.  Virtually no ascites developed in the treatment group; mean vol. of ascites in controls was 3.3 ± 0.38 mL.  OVCAR-3 cells also were cultured in vitro without and with LY294002 (1, 5, and 10 μM) for 24 h.  The no. of cells in 1, 5, and 10 μM LY294002-treated wells was reduced by 27, 56, and 75%, resp., vs. controls.  In vivo and in vitro morphol. studies demonstrated that LY294002 induced marked nuclear pyknosis and diminished cytoplasmic vol. in the tumor cells, confirmed as apoptosis.  Thus, LY294002 significantly inhibits growth and ascites formation of ovarian carcinoma in vivo and markedly inhibits ovarian cancer cell proliferation in vitro, suggesting an important role of PI3-K inhibitors as a potentially useful treatment for women with ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuP8ZJJ_717rVg90H21EOLACvtfcHk0liGEWxYp-YIpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVaqtbw%253D&md5=fa194aa4b60b67ca905e77cfd5e0888d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZaloudek%26aufirst%3DC.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%26aulast%3DJaffe%26aufirst%3DR.%2BB.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520ovarian%2520carcinoma%2520growth%2520inhibition%2520by%2520a%2520phosphatidylinositol%25203-kinase%2520inhibitor%2520%2528LY294002%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lars G. J.  Hammarström</span>, <span class="hlFld-ContribAuthor ">Robert K.  Harmel</span>, <span class="hlFld-ContribAuthor ">Mikael  Granath</span>, <span class="hlFld-ContribAuthor ">Rune  Ringom</span>, <span class="hlFld-ContribAuthor ">Ylva  Gravenfors</span>, <span class="hlFld-ContribAuthor ">Katarina  Färnegårdh</span>, <span class="hlFld-ContribAuthor ">Per H.  Svensson</span>, <span class="hlFld-ContribAuthor ">David  Wennman</span>, <span class="hlFld-ContribAuthor ">Göran  Lundin</span>, <span class="hlFld-ContribAuthor ">Ylva  Roddis</span>, <span class="hlFld-ContribAuthor ">Satish S.  Kitambi</span>, <span class="hlFld-ContribAuthor ">Alexandra  Bernlind</span>, <span class="hlFld-ContribAuthor ">Fredrik  Lehmann</span>, and <span class="hlFld-ContribAuthor ">Patrik  Ernfors</span>  . </span><span class="cited-content_cbyCitation_article-title">The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8577-8592. <a href="https://doi.org/10.1021/acs.jmedchem.6b01009" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BOncolytic%252BEfficacy%252Band%252Bin%252BVivo%252BPharmacokinetics%252Bof%252B%25255B2-%2525284-Chlorophenyl%252529quinolin-4-yl%25255D%252528piperidine-2-yl%252529methanol%252B%252528Vacquinol-1%252529%252BAre%252BGoverned%252Bby%252BDistinct%252BStereochemical%252BFeatures%26aulast%3DHammarstr%25C3%25B6m%26aufirst%3DLars%2BG.%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09072016%26date%3D08092016%26date%3D22092016%26volume%3D59%26issue%3D18%26spage%3D8577%26epage%3D8592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>, and <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">C8-Selective Acylation of Quinoline N-Oxides with α-Oxocarboxylic Acids via Palladium-Catalyzed Regioselective C–H Bond Activation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (15)
                                     , 3722-3725. <a href="https://doi.org/10.1021/acs.orglett.6b01746" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b01746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b01746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b01746%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DC8-Selective%252BAcylation%252Bof%252BQuinoline%252BN-Oxides%252Bwith%252B%2525CE%2525B1-Oxocarboxylic%252BAcids%252Bvia%252BPalladium-Catalyzed%252BRegioselective%252BC%2525E2%252580%252593H%252BBond%252BActivation%26aulast%3DChen%26aufirst%3DXiaopei%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16062016%26date%3D21072016%26date%3D05082016%26volume%3D18%26issue%3D15%26spage%3D3722%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pi‐Tao  Qin</span>, <span class="hlFld-ContribAuthor ">Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Jing‐Yun  Wang</span>, <span class="hlFld-ContribAuthor ">He  Wang</span>, <span class="hlFld-ContribAuthor ">Ming‐Dong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced C2 Alkylation of Heterocyclic N‐Oxides with N‐Hydroxyphthalimide Esters under Metal‐Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (21)
                                     , 4707-4715. <a href="https://doi.org/10.1002/adsc.202000517" title="DOI URL">https://doi.org/10.1002/adsc.202000517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000517%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BC2%252BAlkylation%252Bof%252BHeterocyclic%252BN%2525E2%252580%252590Oxides%252Bwith%252BN%2525E2%252580%252590Hydroxyphthalimide%252BEsters%252Bunder%252BMetal%2525E2%252580%252590Free%252BConditions%26aulast%3DQin%26aufirst%3DPi%25E2%2580%2590Tao%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D21%26spage%3D4707%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">ASG.  Prasad</span>, <span class="hlFld-ContribAuthor ">A. Gopi  Reddy</span>, <span class="hlFld-ContribAuthor ">Venkata Naga Baji  Tokala</span>, <span class="hlFld-ContribAuthor ">K.  Deepthi</span>, <span class="hlFld-ContribAuthor ">T. Bhasakara  Rao</span>, <span class="hlFld-ContribAuthor ">M.V. Basaveswara  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 2,4-disubstituted quinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2020,</strong> <em>28 </em>, 100469. <a href="https://doi.org/10.1016/j.cdc.2020.100469" title="DOI URL">https://doi.org/10.1016/j.cdc.2020.100469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2020.100469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2020.100469%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DSynthesis%252Bof%252Bnovel%252B2%25252C4-disubstituted%252Bquinoline%252Bderivatives%26aulast%3DPrasad%26aufirst%3DASG.%26date%3D2020%26volume%3D28%26spage%3D100469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingping  Quan</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Du</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Hou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Gong</span>, <span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Jingwei  Jiang</span>, <span class="hlFld-ContribAuthor ">Ligong  Lu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Yang</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Li  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00820" title="DOI URL">https://doi.org/10.3389/fchem.2019.00820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00820%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DNovel%252BQuinoline%252BCompound%252BDerivatives%252Bof%252BNSC23925%252Bas%252BPotent%252BReversal%252BAgents%252BAgainst%252BP-Glycoprotein-Mediated%252BMultidrug%252BResistance%26aulast%3DQuan%26aufirst%3DXingping%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonghoon  Moon</span>, <span class="hlFld-ContribAuthor ">Bohyun  Park</span>, <span class="hlFld-ContribAuthor ">Inwon  Kim</span>, <span class="hlFld-ContribAuthor ">Gyumin  Kang</span>, <span class="hlFld-ContribAuthor ">Sanghoon  Shin</span>, <span class="hlFld-ContribAuthor ">Dahye  Kang</span>, <span class="hlFld-ContribAuthor ">Mu-Hyun  Baik</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light induced alkene aminopyridylation using N-aminopyridinium salts as bifunctional reagents. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-12216-3" title="DOI URL">https://doi.org/10.1038/s41467-019-12216-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-12216-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-12216-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DVisible%252Blight%252Binduced%252Balkene%252Baminopyridylation%252Busing%252BN-aminopyridinium%252Bsalts%252Bas%252Bbifunctional%252Breagents%26aulast%3DMoon%26aufirst%3DYonghoon%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen‐Peng  Mai</span>, <span class="hlFld-ContribAuthor ">Jin‐Wei  Yuan</span>, <span class="hlFld-ContribAuthor ">Jun‐Liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiang‐Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Liang‐Ru  Yang</span>, <span class="hlFld-ContribAuthor ">Yong‐Mei  Xiao</span>, <span class="hlFld-ContribAuthor ">Pu  Mao</span>, <span class="hlFld-ContribAuthor ">Ling‐Bo  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Selectfluor‐Mediated Direct C‐H Phosphonation of Quinoxalin‐2(1
              H
              )‐ones under Base and Transition‐Metal Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (37)
                                     , 11066-11070. <a href="https://doi.org/10.1002/slct.201903478" title="DOI URL">https://doi.org/10.1002/slct.201903478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903478%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSelectfluor%2525E2%252580%252590Mediated%252BDirect%252BC%2525E2%252580%252590H%252BPhosphonation%252Bof%252BQuinoxalin%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590ones%252Bunder%252BBase%252Band%252BTransition%2525E2%252580%252590Metal%252BFree%252BConditions%26aulast%3DMai%26aufirst%3DWen%25E2%2580%2590Peng%26date%3D2019%26volume%3D4%26issue%3D37%26spage%3D11066%26epage%3D11070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Weixian  Xi</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Yang</span>, <span class="hlFld-ContribAuthor ">Dylan C.  Dean</span>, <span class="hlFld-ContribAuthor ">Shao-Liang  Zheng</span>, <span class="hlFld-ContribAuthor ">Francis J.  Hornicek</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallization and characterization of small molecular multidrug resistance inhibitor targeting P-glycoprotein, NSC23925 isomers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1193 </em>, 7-13. <a href="https://doi.org/10.1016/j.molstruc.2019.05.010" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DCrystallization%252Band%252Bcharacterization%252Bof%252Bsmall%252Bmolecular%252Bmultidrug%252Bresistance%252Binhibitor%252Btargeting%252BP-glycoprotein%25252C%252BNSC23925%252Bisomers%26aulast%3DGao%26aufirst%3DYan%26date%3D2019%26volume%3D1193%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrii I.  Subota</span>, <span class="hlFld-ContribAuthor ">Anton O.  Lutsenko</span>, <span class="hlFld-ContribAuthor ">Bohdan V.  Vashchenko</span>, <span class="hlFld-ContribAuthor ">Dmitriy M.  Volochnyuk</span>, <span class="hlFld-ContribAuthor ">Vitalina  Levchenko</span>, <span class="hlFld-ContribAuthor ">Yurii V.  Dmytriv</span>, <span class="hlFld-ContribAuthor ">Eduard B.  Rusanov</span>, <span class="hlFld-ContribAuthor ">Alina O.  Gorlova</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Ryabukhin</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Scalable and Straightforward Synthesis of All Isomeric (Cyclo)alkylpiperidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (22)
                                     , 3636-3648. <a href="https://doi.org/10.1002/ejoc.201900450" title="DOI URL">https://doi.org/10.1002/ejoc.201900450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900450%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DScalable%252Band%252BStraightforward%252BSynthesis%252Bof%252BAll%252BIsomeric%252B%252528Cyclo%252529alkylpiperidines%26aulast%3DSubota%26aufirst%3DAndrii%2BI.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D22%26spage%3D3636%26epage%3D3648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang-Hui  Li</span>, <span class="hlFld-ContribAuthor ">Dao-Qing  Dong</span>, <span class="hlFld-ContribAuthor ">Xian-Yong  Yu</span>, <span class="hlFld-ContribAuthor ">Zu-Li  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Direct synthesis of 8-acylated quinoline N-oxides
              via
              palladium-catalyzed selective C–H activation and C(sp
              2
              )–C(sp
              2
              ) cleavage. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (4)
                                     , 1667-1670. <a href="https://doi.org/10.1039/C8NJ05374J" title="DOI URL">https://doi.org/10.1039/C8NJ05374J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ05374J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ05374J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDirect%252Bsynthesis%252Bof%252B8-acylated%252Bquinoline%252BN-oxides%252Bvia%252Bpalladium-catalyzed%252Bselective%252BC%2525E2%252580%252593H%252Bactivation%252Band%252BC%252528sp%252B2%252B%252529%2525E2%252580%252593C%252528sp%252B2%252B%252529%252Bcleavage%26aulast%3DLi%26aufirst%3DGuang-Hui%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D4%26spage%3D1667%26epage%3D1670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shirin  Mollazadeh</span>, <span class="hlFld-ContribAuthor ">Amirhossein  Sahebkar</span>, <span class="hlFld-ContribAuthor ">Farzin  Hadizadeh</span>, <span class="hlFld-ContribAuthor ">Javad  Behravan</span>, <span class="hlFld-ContribAuthor ">Sepideh  Arabzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and functional aspects of P-glycoprotein and its inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2018,</strong> <em>214 </em>, 118-123. <a href="https://doi.org/10.1016/j.lfs.2018.10.048" title="DOI URL">https://doi.org/10.1016/j.lfs.2018.10.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2018.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2018.10.048%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DStructural%252Band%252Bfunctional%252Baspects%252Bof%252BP-glycoprotein%252Band%252Bits%252Binhibitors%26aulast%3DMollazadeh%26aufirst%3DShirin%26date%3D2018%26volume%3D214%26spage%3D118%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  You</span>, <span class="hlFld-ContribAuthor ">Chao  Pi</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(III)‐Catalyzed Selective C8−H Acylmethylation of Quinoline
              N
              ‐Oxides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (21)
                                     , 4068-4072. <a href="https://doi.org/10.1002/adsc.201800659" title="DOI URL">https://doi.org/10.1002/adsc.201800659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800659%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRh%252528III%252529%2525E2%252580%252590Catalyzed%252BSelective%252BC8%2525E2%252588%252592H%252BAcylmethylation%252Bof%252BQuinoline%252BN%252B%2525E2%252580%252590Oxides%26aulast%3DYou%26aufirst%3DChang%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D21%26spage%3D4068%26epage%3D4072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gong-Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Piperidines: Functionalization of Preexisting Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 107-234. <a href="https://doi.org/10.1016/bs.aihch.2017.10.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2017.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2017.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2017.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BPiperidines%25253A%252BFunctionalization%252Bof%252BPreexisting%252BRing%252BSystems%26aulast%3DLiu%26aufirst%3DGong-Qing%26date%3D2018%26spage%3D107%26epage%3D234%26pub%3DElsevier%26date%3D2018%26volume%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxue  Su</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Direct C4–H phosphonation of 8-hydroxyquinoline derivatives employing photoredox catalysis and silver catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (15)
                                     , 2753-2756. <a href="https://doi.org/10.1039/C8OB00370J" title="DOI URL">https://doi.org/10.1039/C8OB00370J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00370J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00370J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDirect%252BC4%2525E2%252580%252593H%252Bphosphonation%252Bof%252B8-hydroxyquinoline%252Bderivatives%252Bemploying%252Bphotoredox%252Bcatalysis%252Band%252Bsilver%252Bcatalysis%26aulast%3DSu%26aufirst%3DXiaoxue%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D15%26spage%3D2753%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  You</span>, <span class="hlFld-ContribAuthor ">Tingting  Yuan</span>, <span class="hlFld-ContribAuthor ">Yanzhen  Huang</span>, <span class="hlFld-ContribAuthor ">Chao  Pi</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium-catalyzed regioselective C8-H amination of quinoline
              N
              -oxides with trifluoroacetamide at room temperature. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (25)
                                     , 4728-4733. <a href="https://doi.org/10.1039/C8OB01108G" title="DOI URL">https://doi.org/10.1039/C8OB01108G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01108G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01108G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRhodium-catalyzed%252Bregioselective%252BC8-H%252Bamination%252Bof%252Bquinoline%252BN%252B-oxides%252Bwith%252Btrifluoroacetamide%252Bat%252Broom%252Btemperature%26aulast%3DYou%26aufirst%3DChang%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D25%26spage%3D4728%26epage%3D4733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramu  Guda</span>, <span class="hlFld-ContribAuthor ">Girijesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajashekar  Korra</span>, <span class="hlFld-ContribAuthor ">Siripireddy  Balaji</span>, <span class="hlFld-ContribAuthor ">Govindu  Dayakar</span>, <span class="hlFld-ContribAuthor ">Rambabu  Palabindela</span>, <span class="hlFld-ContribAuthor ">Prabhakar  Myadaraveni</span>, <span class="hlFld-ContribAuthor ">Narsimha Reddy  Yellu</span>, <span class="hlFld-ContribAuthor ">Mamatha  Kasula</span>. </span><span class="cited-content_cbyCitation_article-title">EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology B: Biology</span><span> <strong>2017,</strong> <em>176 </em>, 69-80. <a href="https://doi.org/10.1016/j.jphotobiol.2017.09.010" title="DOI URL">https://doi.org/10.1016/j.jphotobiol.2017.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotobiol.2017.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotobiol.2017.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520B%253A%2520Biology%26atitle%3DEGFR%25252C%252BHER2%252Btarget%252Bbased%252Bmolecular%252Bdocking%252Banalysis%25252C%252Bin%252Bvitro%252Bscreening%252Bof%252B2%25252C%252B4%25252C%252B5-trisubstituted%252Bimidazole%252Bderivatives%252Bas%252Bpotential%252Banti-oxidant%252Band%252Bcytotoxic%252Bagents%26aulast%3DGuda%26aufirst%3DRamu%26date%3D2017%26volume%3D176%26spage%3D69%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huijie  Qiao</span>, <span class="hlFld-ContribAuthor ">Suyan  Sun</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongmei  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaomeng  Yu</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Zhongxian  Li</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Merging photoredox catalysis with transition metal catalysis: site-selective C4 or C5-H phosphonation of 8-aminoquinoline amides. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (10)
                                     , 1981-1986. <a href="https://doi.org/10.1039/C7QO00305F" title="DOI URL">https://doi.org/10.1039/C7QO00305F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00305F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00305F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DMerging%252Bphotoredox%252Bcatalysis%252Bwith%252Btransition%252Bmetal%252Bcatalysis%25253A%252Bsite-selective%252BC4%252Bor%252BC5-H%252Bphosphonation%252Bof%252B8-aminoquinoline%252Bamides%26aulast%3DQiao%26aufirst%3DHuijie%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D10%26spage%3D1981%26epage%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Jacson K.  Shen</span>, <span class="hlFld-ContribAuthor ">Edwin  Choy</span>, <span class="hlFld-ContribAuthor ">Zhan  Zhang</span>, <span class="hlFld-ContribAuthor ">Henry J.  Mankin</span>, <span class="hlFld-ContribAuthor ">Francis J.  Hornicek</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep25659" title="DOI URL">https://doi.org/10.1038/srep25659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep25659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep25659%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPharmacokinetics%252Band%252Btolerability%252Bof%252BNSC23925b%25252C%252Ba%252Bnovel%252BP-glycoprotein%252Binhibitor%25253A%252Bpreclinical%252Bstudy%252Bin%252Bmice%252Band%252Brats%26aulast%3DGao%26aufirst%3DYan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunan  Ye</span>, <span class="hlFld-ContribAuthor ">Jacson  Shen</span>, <span class="hlFld-ContribAuthor ">Edwin  Choy</span>, <span class="hlFld-ContribAuthor ">Cao  Yang</span>, <span class="hlFld-ContribAuthor ">Henry  Mankin</span>, <span class="hlFld-ContribAuthor ">Francis  Hornicek</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (2)
                                     , 349-356. <a href="https://doi.org/10.1007/s00280-015-2944-z" title="DOI URL">https://doi.org/10.1007/s00280-015-2944-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-015-2944-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-015-2944-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3Dp53%252Boverexpression%252Bincreases%252Bchemosensitivity%252Bin%252Bmultidrug-resistant%252Bosteosarcoma%252Bcell%252Blines%26aulast%3DYe%26aufirst%3DShunan%26date%3D2016%26date%3D2015%26volume%3D77%26issue%3D2%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinxin  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Lici A.  Schurig-Briccio</span>, <span class="hlFld-ContribAuthor ">Steffen  Lindert</span>, <span class="hlFld-ContribAuthor ">Carolyn  Shoen</span>, <span class="hlFld-ContribAuthor ">Reese  Hitchings</span>, <span class="hlFld-ContribAuthor ">Jikun  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Noman  Baig</span>, <span class="hlFld-ContribAuthor ">Tianhui  Zhou</span>, <span class="hlFld-ContribAuthor ">Boo Kyung  Kim</span>, <span class="hlFld-ContribAuthor ">Dean C.  Crick</span>, <span class="hlFld-ContribAuthor ">Michael  Cynamon</span>, <span class="hlFld-ContribAuthor ">J. Andrew  McCammon</span>, <span class="hlFld-ContribAuthor ">Robert B.  Gennis</span>, <span class="hlFld-ContribAuthor ">Eric  Oldfield</span>. </span><span class="cited-content_cbyCitation_article-title">Antiinfectives targeting enzymes and the proton motive force. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2015,</strong> <em>112 </em>
                                    (51)
                                     , E7073-E7082. <a href="https://doi.org/10.1073/pnas.1521988112" title="DOI URL">https://doi.org/10.1073/pnas.1521988112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1521988112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1521988112%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DAntiinfectives%252Btargeting%252Benzymes%252Band%252Bthe%252Bproton%252Bmotive%252Bforce%26aulast%3DFeng%26aufirst%3DXinxin%26date%3D2015%26date%3D2015%26volume%3D112%26issue%3D51%26spage%3DE7073%26epage%3DE7082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.P.  Ween</span>, <span class="hlFld-ContribAuthor ">M.A.  Armstrong</span>, <span class="hlFld-ContribAuthor ">M.K.  Oehler</span>, <span class="hlFld-ContribAuthor ">C.  Ricciardelli</span>. </span><span class="cited-content_cbyCitation_article-title">The role of ABC transporters in ovarian cancer progression and chemoresistance. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2015,</strong> <em>96 </em>
                                    (2)
                                     , 220-256. <a href="https://doi.org/10.1016/j.critrevonc.2015.05.012" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2015.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2015.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2015.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DThe%252Brole%252Bof%252BABC%252Btransporters%252Bin%252Bovarian%252Bcancer%252Bprogression%252Band%252Bchemoresistance%26aulast%3DWeen%26aufirst%3DM.P.%26date%3D2015%26volume%3D96%26issue%3D2%26spage%3D220%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Yang</span>, <span class="hlFld-ContribAuthor ">Jacson  Shen</span>, <span class="hlFld-ContribAuthor ">Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Yong  Feng</span>, <span class="hlFld-ContribAuthor ">Yichun  Guan</span>, <span class="hlFld-ContribAuthor ">Zhan  Zhang</span>, <span class="hlFld-ContribAuthor ">Henry  Mankin</span>, <span class="hlFld-ContribAuthor ">Francis J.  Hornicek</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2015,</strong> <em>137 </em>
                                    (8)
                                     , 2029-2039. <a href="https://doi.org/10.1002/ijc.29574" title="DOI URL">https://doi.org/10.1002/ijc.29574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.29574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.29574%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DNsc23925%252Bprevents%252Bthe%252Bdevelopment%252Bof%252Bpaclitaxel%252Bresistance%252Bby%252Binhibiting%252Bthe%252Bintroduction%252Bof%252BP-glycoprotein%252Band%252Benhancing%252Bapoptosis%26aulast%3DYang%26aufirst%3DXiaoqian%26date%3D2015%26date%3D2015%26volume%3D137%26issue%3D8%26spage%3D2029%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  Feng</span>, <span class="hlFld-ContribAuthor ">Yan  Gao</span>, <span class="hlFld-ContribAuthor ">Jacson  Shen</span>, <span class="hlFld-ContribAuthor ">Edwin  Choy</span>, <span class="hlFld-ContribAuthor ">Gregory  Cote</span>, <span class="hlFld-ContribAuthor ">David  Harmon</span>, <span class="hlFld-ContribAuthor ">Zhan  Zhang</span>, <span class="hlFld-ContribAuthor ">Henry  Mankin</span>, <span class="hlFld-ContribAuthor ">Francis J.  Hornicek</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Gynecologic Oncology</span><span> <strong>2015,</strong> <em>137 </em>
                                    (1)
                                     , 134-142. <a href="https://doi.org/10.1016/j.ygyno.2015.02.002" title="DOI URL">https://doi.org/10.1016/j.ygyno.2015.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygyno.2015.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygyno.2015.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DGynecologic%2520Oncology%26atitle%3DNSC23925%252Bprevents%252Bthe%252Bemergence%252Bof%252Bmultidrug%252Bresistance%252Bin%252Bovarian%252Bcancer%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DYang%26aufirst%3DXiaoqian%26date%3D2015%26volume%3D137%26issue%3D1%26spage%3D134%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Greg F.  Miknis</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Stevens</span>, <span class="hlFld-ContribAuthor ">Luke E.  Smith</span>, <span class="hlFld-ContribAuthor ">David A.  Ostrov</span>, <span class="hlFld-ContribAuthor ">Mair E.A.  Churchill</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel Asf1–H3/H4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 963-968. <a href="https://doi.org/10.1016/j.bmcl.2014.11.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bnovel%252BAsf1%2525E2%252580%252593H3%25252FH4%252Binhibitors%26aulast%3DMiknis%26aufirst%3DGreg%2BF.%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D963%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navneet  Kishore</span>, <span class="hlFld-ContribAuthor ">Brigitte  Binneman</span>, <span class="hlFld-ContribAuthor ">Anita  Mahapatra</span>, <span class="hlFld-ContribAuthor ">Maryna  van de Venter</span>, <span class="hlFld-ContribAuthor ">Debbie  du Plessis-Stoman</span>, <span class="hlFld-ContribAuthor ">Gerhardt  Boukes</span>, <span class="hlFld-ContribAuthor ">Peter  Houghton</span>, <span class="hlFld-ContribAuthor ">J.J.  Marion Meyer</span>, <span class="hlFld-ContribAuthor ">Namrita  Lall</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxicity of synthesized 1,4-naphthoquinone analogues on selected human cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 5013-5019. <a href="https://doi.org/10.1016/j.bmc.2014.06.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCytotoxicity%252Bof%252Bsynthesized%252B1%25252C4-naphthoquinone%252Banalogues%252Bon%252Bselected%252Bhuman%252Bcancer%252Bcell%252Blines%26aulast%3DKishore%26aufirst%3DNavneet%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D5013%26epage%3D5019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Jiangwei  Ma</span>, <span class="hlFld-ContribAuthor ">Xueying  Liu</span>, <span class="hlFld-ContribAuthor ">Shengyong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of novel quinoline–docetaxel analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (13)
                                     , 2867-2870. <a href="https://doi.org/10.1016/j.bmcl.2014.04.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252Bquinoline%2525E2%252580%252593docetaxel%252Banalogues%26aulast%3DChen%26aufirst%3DMing%26date%3D2014%26volume%3D24%26issue%3D13%26spage%3D2867%26epage%3D2870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X  Yang</span>, <span class="hlFld-ContribAuthor ">P  Yang</span>, <span class="hlFld-ContribAuthor ">J  Shen</span>, <span class="hlFld-ContribAuthor ">E  Osaka</span>, <span class="hlFld-ContribAuthor ">E  Choy</span>, <span class="hlFld-ContribAuthor ">G  Cote</span>, <span class="hlFld-ContribAuthor ">D  Harmon</span>, <span class="hlFld-ContribAuthor ">Z  Zhang</span>, <span class="hlFld-ContribAuthor ">H  Mankin</span>, <span class="hlFld-ContribAuthor ">F J  Hornicek</span>, <span class="hlFld-ContribAuthor ">Z  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2014,</strong> <em>110 </em>
                                    (12)
                                     , 2896-2904. <a href="https://doi.org/10.1038/bjc.2014.254" title="DOI URL">https://doi.org/10.1038/bjc.2014.254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2014.254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2014.254%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DPrevention%252Bof%252Bmultidrug%252Bresistance%252B%252528MDR%252529%252Bin%252Bosteosarcoma%252Bby%252BNSC23925%26aulast%3DYang%26aufirst%3DX%26date%3D2014%26date%3D2014%26volume%3D110%26issue%3D12%26spage%3D2896%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satish Srinivas  Kitambi</span>, <span class="hlFld-ContribAuthor ">Enrique M.  Toledo</span>, <span class="hlFld-ContribAuthor ">Dmitry  Usoskin</span>, <span class="hlFld-ContribAuthor ">Shimei  Wee</span>, <span class="hlFld-ContribAuthor ">Aditya  Harisankar</span>, <span class="hlFld-ContribAuthor ">Richard  Svensson</span>, <span class="hlFld-ContribAuthor ">Kristmundur  Sigmundsson</span>, <span class="hlFld-ContribAuthor ">Christina  Kalderén</span>, <span class="hlFld-ContribAuthor ">Mia  Niklasson</span>, <span class="hlFld-ContribAuthor ">Soumi  Kundu</span>, <span class="hlFld-ContribAuthor ">Sergi  Aranda</span>, <span class="hlFld-ContribAuthor ">Bengt  Westermark</span>, <span class="hlFld-ContribAuthor ">Lene  Uhrbom</span>, <span class="hlFld-ContribAuthor ">Michael  Andäng</span>, <span class="hlFld-ContribAuthor ">Peter  Damberg</span>, <span class="hlFld-ContribAuthor ">Sven  Nelander</span>, <span class="hlFld-ContribAuthor ">Ernest  Arenas</span>, <span class="hlFld-ContribAuthor ">Per  Artursson</span>, <span class="hlFld-ContribAuthor ">Julian  Walfridsson</span>, <span class="hlFld-ContribAuthor ">Karin  Forsberg Nilsson</span>, <span class="hlFld-ContribAuthor ">Lars G.J.  Hammarström</span>, <span class="hlFld-ContribAuthor ">Patrik  Ernfors</span>. </span><span class="cited-content_cbyCitation_article-title">RETRACTED: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2014,</strong> <em>157 </em>
                                    (2)
                                     , 313-328. <a href="https://doi.org/10.1016/j.cell.2014.02.021" title="DOI URL">https://doi.org/10.1016/j.cell.2014.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2014.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2014.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DRETRACTED%25253A%252BVulnerability%252Bof%252BGlioblastoma%252BCells%252Bto%252BCatastrophic%252BVacuolization%252Band%252BDeath%252BInduced%252Bby%252Ba%252BSmall%252BMolecule%26aulast%3DKitambi%26aufirst%3DSatish%25C2%25A0Srinivas%26date%3D2014%26volume%3D157%26issue%3D2%26spage%3D313%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna A  Bulysheva</span>, <span class="hlFld-ContribAuthor ">Gary L  Bowlin</span>, <span class="hlFld-ContribAuthor ">Stella P  Petrova</span>, <span class="hlFld-ContribAuthor ">W Andrew  Yeudall</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Materials</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 055009. <a href="https://doi.org/10.1088/1748-6041/8/5/055009" title="DOI URL">https://doi.org/10.1088/1748-6041/8/5/055009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1748-6041/8/5/055009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1748-6041%2F8%2F5%2F055009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Materials%26atitle%3DEnhanced%252Bchemoresistance%252Bof%252Bsquamous%252Bcarcinoma%252Bcells%252Bgrown%252Bin%252B3D%252Bcryogenic%252Belectrospun%252Bscaffolds%26aulast%3DBulysheva%26aufirst%3DAnna%2BA%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3D055009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Wu</span>, <span class="hlFld-ContribAuthor ">Chao  Pi</span>, <span class="hlFld-ContribAuthor ">Xiuling  Cui</span>, <span class="hlFld-ContribAuthor ">Jie  Bai</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Direct C-2 Alkylation of Quinoline
              N
              -Oxides with Ethers
              via
              Palladium-Catalyzed Dehydrogenative Cross-Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2013,</strong> <em>355 </em>
                                    (10)
                                     , 1971-1976. <a href="https://doi.org/10.1002/adsc.201300111" title="DOI URL">https://doi.org/10.1002/adsc.201300111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300111%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDirect%252BC-2%252BAlkylation%252Bof%252BQuinoline%252BN%252B-Oxides%252Bwith%252BEthers%252Bvia%252BPalladium-Catalyzed%252BDehydrogenative%252BCross-Coupling%252BReaction%26aulast%3DWu%26aufirst%3DZhiyong%26date%3D2013%26date%3D2013%26volume%3D355%26issue%3D10%26spage%3D1971%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Waël  Zeinyeh</span>, <span class="hlFld-ContribAuthor ">Zahia  Mahiout</span>, <span class="hlFld-ContribAuthor ">Sylvie  Radix</span>, <span class="hlFld-ContribAuthor ">Thierry  Lomberget</span>, <span class="hlFld-ContribAuthor ">Axel  Dumoulin</span>, <span class="hlFld-ContribAuthor ">Roland  Barret</span>, <span class="hlFld-ContribAuthor ">Catherine  Grenot</span>, <span class="hlFld-ContribAuthor ">Luc  Rocheblave</span>, <span class="hlFld-ContribAuthor ">Eva-Laure  Matera</span>, <span class="hlFld-ContribAuthor ">Charles  Dumontet</span>, <span class="hlFld-ContribAuthor ">Nadia  Walchshofer</span>. </span><span class="cited-content_cbyCitation_article-title">Progesterone–adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: Design, synthesis, characterization and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2012,</strong> <em>77 </em>
                                    (12)
                                     , 1177-1191. <a href="https://doi.org/10.1016/j.steroids.2012.07.010" title="DOI URL">https://doi.org/10.1016/j.steroids.2012.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2012.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2012.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DProgesterone%2525E2%252580%252593adenine%252Bhybrids%252Bas%252Bbivalent%252Binhibitors%252Bof%252BP-glycoprotein-mediated%252Bmultidrug%252Befflux%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bcharacterization%252Band%252Bbiological%252Bevaluation%26aulast%3DZeinyeh%26aufirst%3DWa%25C3%25ABl%26date%3D2012%26volume%3D77%26issue%3D12%26spage%3D1177%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shubhanjali  Shukla</span>, <span class="hlFld-ContribAuthor ">Radhey Shyam  Srivastava</span>, <span class="hlFld-ContribAuthor ">Sushant Kumar  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Ajit  Sodhi</span>, <span class="hlFld-ContribAuthor ">Pankaj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular docking and Biological evaluation of 4-Cycloalkylidineamino 1, 2-Naphthoquinone Semicarbazones as Anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Asian Pacific Journal of Tropical Biomedicine</span><span> <strong>2012,</strong> <em>2 </em>
                                    (2)
                                     , S1040-S1046. <a href="https://doi.org/10.1016/S2221-1691(12)60358-X" title="DOI URL">https://doi.org/10.1016/S2221-1691(12)60358-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2221-1691(12)60358-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2221-1691%2812%2960358-X%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Pacific%2520Journal%2520of%2520Tropical%2520Biomedicine%26atitle%3DSynthesis%25252C%252BMolecular%252Bdocking%252Band%252BBiological%252Bevaluation%252Bof%252B4-Cycloalkylidineamino%252B1%25252C%252B2-Naphthoquinone%252BSemicarbazones%252Bas%252BAnticancer%252Bagents%26aulast%3DShukla%26aufirst%3DShubhanjali%26date%3D2012%26volume%3D2%26issue%3D2%26spage%3DS1040%26epage%3DS1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>5</b> (NSC23925) Isomers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-(4-methoxyphenyl)ethanone, KOH, EtOH, 85 °C, 24 h, 50%; (b) concd H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux overnight, 70%; (c) 2-bromopyridine, n-BuLi, Et<sub>2</sub>O–THF, −78 °C, 2 h, 91%; (d) NaBH<sub>4</sub>, EtOH, 0 °C, 1 h, 60%; (e) H<sub>2</sub>, PtO<sub>2</sub>, concd HCl, MeOH, 20 °C, 2 h; (f) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, THF, 0 to rt,overnight; (g) chiral HPLC; (h) HCl/EtOH, 20 °C.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of <b>5</b> isomers on reverse drug resistance in SKOV-3<sub>TR</sub> cell line. Cells were treated with the paclitaxel and isomers (<b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b>) in RPMI1640 complete media at the indicated concentrations. The relative sensitivity of each line to paclitaxel was determined by MTT analysis 6 days posttreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reverse multidrug resistance isomer <b>11</b> in MCF-7adr and SW480<sub>TR</sub> cell lines. Cells were treated with paclitaxel, doxorubicin, or mitoxantrone and isomer <b>11</b> in RPMI1640 complete media at the indicated concentrations. The relative sensitivity of each line to the indicated drugs was determined by MTT analysis 6 days posttreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Calcein AM efflux from isomer <b>11</b>-treated MCF-7adr and SW480<sub>TR</sub> cell line cells. The calcein AM assay was optimized and performed using the Vybrant Multidrug Resistance kit. Cells were seeded at 50 000 cells/well (100 μL of culture medium) in a 96-well plate and incubated for 24 h. MCF-7adr or SW480<sub>TR</sub> cells in triplicate were treated with <b>11</b> for 1 h and then incubated in calcein AM for 30 min. The cell fluorescence images were acquired by a fluorescence microscope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Isomer <b>11</b> in combination with doxorubicin significantly induces cell death and apoptosis. A: Cell death induced by isomer <b>11</b> in combination with doxorubicin on MCF-7adr and SW480<sub>TR</sub> cells. B: Cell apoptosis induced by <b>11</b> in combination with doxorubicin on MCF-7adr and SW480<sub>TR</sub> cells. Cells were seeded at a density of 8000 cells per well in a 96-well plate for 24 h. The cells were then treated with <b>11</b>, doxorubicin, or a combination of the two drugs for an additional 48 h. The cells were lysed with 10% NP-40, and the M30-Apoptosense ELISA assay was performed as described in Materials and Methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/medium/jm-2012-00117u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of combination treatment with <b>11</b> and paclitaxel on tumor growth in vivo. A: Tumors were measured twice a week with a digital caliper. Tumor volume (mm<sup>3</sup>) was calculated as (<i>W</i><sup>2</sup> × <i>L</i>)/2, where <i>W</i> is width and <i>L</i> is length. B: Representative images of dissected tumor tissues from treated nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm300117u/production/images/large/jm-2012-00117u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300117u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i34">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1038%2Fnrd1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=16518375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance in cancer</span></div><div class="casAuthors">Szakacs, Gergely; Paterson, Jill K.; Ludwig, Joseph A.; Booth-Genthe, Catherine; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-234</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy.  In most cases, multiple drugs are used, as resistance to single agents occurs almost universally.  For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chem. structures - multidrug resistance - has been a major goal of cancer biologists during the past 35 years.  Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.  We describe various approaches to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7LUp3JikHr7Vg90H21EOLACvtfcHk0ljcYze5_XEtUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr8%253D&md5=67ca376f65aa58a71288167f6815a896</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1984%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gillet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F138920111795163931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21118086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Ohsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=686-692&author=J.+P.+Gilletauthor=M.+M.+Gottesman&title=Advances+in+the+molecular+detection+of+ABC+transporters+involved+in+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer</span></div><div class="casAuthors">Gillet, Jean-Pierre; Gottesmann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">686-692</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-Binding Cassette (ABC) transporters are important mediators of multidrug resistance (MDR) in patients with cancer.  Although their role in MDR has been extensively studied in vitro, their value in predicting response to chemotherapy has yet to be fully detd.  Establishing a mol. diagnostic assay dedicated to the quantitation of ABC transporter genes is therefore crit. to investigate their involvement in clin. MDR.  In this article, we provide an overview of the methodologies that have been applied to analyze the mRNA expression levels of ABC transporters, by describing the technol., its pros and cons, and the exptl. protocols that have been followed.  We also discuss recent studies performed in our lab. that assess the ability of the currently available high-throughput gene expression profiling platforms to discriminate between highly homologous genes.  This work led to the conclusion that high-throughput TaqMan-based qRT-PCR platforms provide standardized clin. assays for the mol. detection of ABC transporters and other families of highly homologous MDR-linked genes encoding, for example, the uptake transporters (solute carriers-SLCs) and the phase I and II metab. enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxc4ollS9ZQbVg90H21EOLACvtfcHk0lgr_oOALg4-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Ohsbw%253D&md5=bd4eddd90da2c343d61dbecec991621d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138920111795163931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920111795163931%26sid%3Dliteratum%253Aachs%26aulast%3DGillet%26aufirst%3DJ.%2BP.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DAdvances%2520in%2520the%2520molecular%2520detection%2520of%2520ABC%2520transporters%2520involved%2520in%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2011%26volume%3D12%26spage%3D686%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yusuf, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamendola, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiden, M. V.</span><span> </span><span class="NLM_article-title">Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F1568009033333754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=12570657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVGntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=1-19&author=R.+Z.+Yusufauthor=Z.+Duanauthor=D.+E.+Lamendolaauthor=R.+T.+Pensonauthor=M.+V.+Seiden&title=Paclitaxel+resistance%3A+molecular+mechanisms+and+pharmacologic+manipulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation</span></div><div class="casAuthors">Yusuf, R. Z.; Duan, Z.; Lamendola, D. E.; Penson, R. T.; Seiden, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been approx. ten years since the Food and Drug Administration (FDA) approved paclitaxel for the treatment of platinum resistant epithelial ovarian carcinoma.  Since the approval, the drug has found therapeutic applications in a variety of schedules and in a wide variety of epithelial malignancies.  Its novel mechanism of action provided the hope that it would demonstrate anti-neoplastic activity in multidrug resistant tumor cells.  Unfortunately, as with other chemotherapeutic drugs, resistance is commonly seen.  Lab. investigation has defined a wide variety of resistance mechanisms including overexpression of multidrug resistance (MDR-1) gene, mol. changes in the target mol. (β-tubulin), changes in apoptotic regulatory and mitosis checkpoint proteins, and more recently changes in lipid compn. and potentially the overexpression of interleukin 6 (IL-6).  This review describes the in vitro mol. data that define and support the various mechanisms of resistance and critically evaluates the evidence for the participation of these mechanisms in clin. relevant paclitaxel resistance.  This review also explores pharmacol. attempts to modulate paclitaxel resistance, principally through inhibition of the MDR-1 drug efflux pump.  Future avenues for drug resistance research and its pharmacol. manipulation in the clinic are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozwrhfHI8_-7Vg90H21EOLACvtfcHk0lgr_oOALg4-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVGntg%253D%253D&md5=6f173a1a569fa11e38b9ddb2af239aca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568009033333754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033333754%26sid%3Dliteratum%253Aachs%26aulast%3DYusuf%26aufirst%3DR.%2BZ.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DLamendola%26aufirst%3DD.%2BE.%26aulast%3DPenson%26aufirst%3DR.%2BT.%26aulast%3DSeiden%26aufirst%3DM.%2BV.%26atitle%3DPaclitaxel%2520resistance%253A%2520molecular%2520mechanisms%2520and%2520pharmacologic%2520manipulation%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lgr_oOALg4-SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Duan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F. J.</span><span> </span><span class="NLM_article-title">NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7415&author=Z.+Duanauthor=E.+Choyauthor=F.+J.+Hornicek&title=NSC23925%2C+identified+in+a+high-throughput+cell-based+screen%2C+reverses+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DHornicek%26aufirst%3DF.%2BJ.%26atitle%3DNSC23925%252C%2520identified%2520in%2520a%2520high-throughput%2520cell-based%2520screen%252C%2520reverses%2520multidrug%2520resistance%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Conseil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P.</span><span> </span><span class="NLM_article-title">Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters</span> <span class="citation_source-journal">Pharmacogenet. Genom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1097%2F01.fpc.0000167333.38528.ec" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=16006996" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=523-533&author=G.+Conseilauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Polymorphisms+of+MRP1+%28ABCC1%29+and+related+ATP-dependent+drug+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F01.fpc.0000167333.38528.ec&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.fpc.0000167333.38528.ec%26sid%3Dliteratum%253Aachs%26aulast%3DConseil%26aufirst%3DG.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DPolymorphisms%2520of%2520MRP1%2520%2528ABCC1%2529%2520and%2520related%2520ATP-dependent%2520drug%2520transporters%26jtitle%3DPharmacogenet.%2520Genom.%26date%3D2005%26volume%3D15%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The challenge of exploiting ABCG2 in the clinic</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.2174%2F138920111795163913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21118093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1OhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=595-608&author=R.+W.+Robeyauthor=C.+Ieranoauthor=Z.+Zhanauthor=S.+E.+Bates&title=The+challenge+of+exploiting+ABCG2+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of exploiting ABCG2 in the clinic</span></div><div class="casAuthors">Robey, Robert W.; Ierano, Caterina; Zhan, Zhirong; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  ABCG2, or breast cancer resistance protein (BCRP), is an ATP-binding cassette half transporter that has been shown to transport a wide range of substrates including chemotherapeutics, antivirals, antibiotics and flavonoids.  Given its wide range of substrates, much work has been dedicated to developing ABCG2 as a clin. target.  But where can we intervene clin. and how can we avoid the mistakes made in past clin. trials targeting P-glycoprotein.  This review will summarize the normal tissue distribution, cancer tissue expression, substrates and inhibitors of ABCG2, and highlight the challenges presented in exploiting ABCG2 in the clinic.  We discuss the possibility of inhibiting ABCG2, so as to increase oral bioavailability or increase drug penetration into sanctuary sites, esp. the central nervous system; and at the other end of the spectrum, the possibility of improving ABCG2 function, in the case of gout caused by a single nucleotide polymphism.  Together, these aspects of ABCG2/BCRP make the protein a target of continuing interest for oncologists, biologists, and pharmacologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNSJ3cQu16BLVg90H21EOLACvtfcHk0ljiDxzYBcxCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1OhsLs%253D&md5=4da2cfd21a7c63f6b7cb357645394d4b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F138920111795163913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920111795163913%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DZhan%26aufirst%3DZ.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520challenge%2520of%2520exploiting%2520ABCG2%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2011%26volume%3D12%26spage%3D595%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">Strategies for reversing drug resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7512-7523&author=T.+Fojoauthor=S.+Bates&title=Strategies+for+reversing+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DStrategies%2520for%2520reversing%2520drug%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7512%26epage%3D7523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Morjani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madoulet, C.</span><span> </span><span class="NLM_article-title">Immunosuppressors as multidrug resistance reversal agents</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">596</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1007%2F978-1-60761-416-6_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=19949935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=596&publication_year=2010&pages=433-446&author=H.+Morjaniauthor=C.+Madoulet&title=Immunosuppressors+as+multidrug+resistance+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressors as multidrug resistance reversal agents</span></div><div class="casAuthors">Morjani, Hamid; Madoulet, Claudie</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">596</span>
        (<span class="NLM_cas:issue">Multi-Drug Resistance in Cancer</span>),
    <span class="NLM_cas:pages">433-446</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Multidrug-resistance (MDR) is the major reason for failure of cancer therapy.  ATP-binding cassette (ABC) transporters contribute to drug resistance via ATP-dependent drug efflux.  P-glycoprotein (Pgp), which is encoded by MDR1 gene, confers resistance to certain anticancer agents.  The development of agents able to modulate MDR mediated by Pgp and other ABC transporters remained a major goal for the past 20 years.  The calcium blocker verapamil was the first drug shown to be a modulator of Pgp, and since many different chem. compds. have been shown to exert the same effect in vitro by blocking Pgp activity.  These included particularly immunosuppressors.  Cyclosporin A (CSA) was the first immunosuppressor that have been shown to modulate Pgp activity in lab. models and entered very early into clin. trials for reversal of MDR.  The proof of reversing activity of CSA was found in phase II studies with myeloma and acute leukemia.  In phase III studies, the results were less convincing regarding the response rate, progression-free survival, and overall survival, which were detected in advanced refractory myeloma.  The non-immunosuppressive deriv. PSC833 (valspodar) was subsequently developed.  This compd. showed tenfold higher potency in reversal of MDR mediated by Pgp.  However, pharmacokinetic interactions required redns. in the dose of the concurrently administered anticancer agents.  The pharmacokinetic interactions were likely because of decreased clearance of the anticancer agents, possibly as a result of Pgp inhibition in organs such as the gastrointestinal tract and kidney, as well as inhibition of cytochrome P 450.  Finally, CSA and PSC833 have been shown also to modulate the ceramide metab. which stands as second messenger of anticancer agent-induced apoptosis.  In fact, CSA and PSC833 are also able to resp. inhibit ceramide glycosylation and stimulate de novo ceramide synthesis.  This could enhance the cellular level of ceramide and potentiate apoptosis induced by some anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrek9xZV-6xrrVg90H21EOLACvtfcHk0lgNYjZx178F1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKhurs%253D&md5=197eccb0bb61c8b9424e45ab87dc3b1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-416-6_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-416-6_19%26sid%3Dliteratum%253Aachs%26aulast%3DMorjani%26aufirst%3DH.%26aulast%3DMadoulet%26aufirst%3DC.%26atitle%3DImmunosuppressors%2520as%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D596%26spage%3D433%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tamaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ierano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">The controversial role of ABC transporters in clinical oncology</span> <span class="citation_source-journal">Essays Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1042%2Fbse0500209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=21967059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGrsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=209-232&author=A.+Tamakiauthor=C.+Ieranoauthor=G.+Szakacsauthor=R.+W.+Robeyauthor=S.+E.+Bates&title=The+controversial+role+of+ABC+transporters+in+clinical+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The controversial role of ABC transporters in clinical oncology</span></div><div class="casAuthors">Tamaki, Akina; Ierano, Caterina; Szakacs, Gergely; Robey, Robert W.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Essays in Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-232</span>CODEN:
                <span class="NLM_cas:coden">ESBIAV</span>;
        ISSN:<span class="NLM_cas:issn">0071-1365</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The phenomenon of multidrug resistance in cancer is often assocd. with the overexpression of the ABC (ATP-binding cassette) transporters Pgp (P-glycoprotein) (ABCB1), MRP1 (multidrug resistance-assocd. protein 1) (ABCC1) and ABCG2 [BCRP (breast cancer resistance protein)].  Since the discovery of Pgp over 35 years ago, studies have convincingly linked ABC transporter expression to poor outcome in several cancer types, leading to the development of transporter inhibitors.  Three generations of inhibitors later, we are still no closer to validating the 'Pgp hypothesis', the idea that increased chemotherapy efficacy can be achieved by inhibition of transporter-mediated efflux.  In this chapter, we highlight the difficulties and past failures encountered in the development of clin. inhibitors of ABC transporters.  We discuss the challenges that remain in our effort to exploit decades of work on ABC transporters in oncol.  In learning from past mistakes, it is hoped that ABC transporters can be developed as targets for clin. intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTf-JsvF3tlLVg90H21EOLACvtfcHk0lgNYjZx178F1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGrsb7O&md5=3c63559612797c2339f046019985def9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2Fbse0500209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbse0500209%26sid%3Dliteratum%253Aachs%26aulast%3DTamaki%26aufirst%3DA.%26aulast%3DIerano%26aufirst%3DC.%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DThe%2520controversial%2520role%2520of%2520ABC%2520transporters%2520in%2520clinical%2520oncology%26jtitle%3DEssays%2520Biochem.%26date%3D2011%26volume%3D50%26spage%3D209%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span> </span><span class="NLM_article-title">Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1007%2Fs00280-003-0742-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=14666379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=349-356&author=L.+Fuauthor=Y.+Liangauthor=L.+Dengauthor=Y.+Dingauthor=L.+Chenauthor=Y.+Yeauthor=X.+Yangauthor=Q.+Pan&title=Characterization+of+tetrandrine%2C+a+potent+inhibitor+of+P-glycoprotein-mediated+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance</span></div><div class="casAuthors">Fu, Liwu; Liang, Yongju; Deng, Liwen; Ding, Yan; Chen, Liming; Ye, Yanli; Yang, Xiaoping; Pan, Qichao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-356</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is one of the main obstacles in tumor chemotherapy.  A promising approach to solving this problem is to utilize a nontoxic and potent modulator able to reverse MDR, which in combination with anticancer drugs increases the anticancer effect.  Expts. were carried out to examine the potential of tetrandrine (Tet) as a MDR-reversing agent.  Survival of cells incubated with Tet at 2.5 μmol/l for 72 h was over 90%.  Tet at 2.5 μmol/l almost completely reversed resistance to vincristine (VCR) in KBv200 cells.  Tet at a concn. as low as 0.625 μmol/l produced a 7.6-fold reversal of MDR, but showed no effect on the sensitivity of drug-sensitive KB cells in vitro.  In the KBv200 cell xenograft model in nude mice, neither Tet nor VCR inhibited tumor growth.  However, VCR and Tet combined inhibited tumor growth by 45.7%, 61.2% and 55.7% in three independent exptl. settings.  In the KB cell xenograft model in nude mice, Tet did not inhibit tumor growth, but VCR and the combination of VCR and Tet inhibited tumor growth by 40.6% and 41.6%, resp.  Mechanism studies showed that Tet inhibited [3H]azidopine photoaffinity labeling of P-gp and increased accumulation of VCR in MDR KBv200 cells in a concn.-dependent manner.  The results suggest that Tet is a potent MDR-reversing agent in vitro and in vivo.  Its mechanism of action is via directly binding to P-gp and increasing intracellular VCR accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0IG_UCsUo7Vg90H21EOLACvtfcHk0lgcYPPmrnZefg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWhu7Y%253D&md5=3e1896069b4095527085849ba771405f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0742-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0742-5%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DQ.%26atitle%3DCharacterization%2520of%2520tetrandrine%252C%2520a%2520potent%2520inhibitor%2520of%2520P-glycoprotein-mediated%2520multidrug%2520resistance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span> </span><span class="NLM_article-title">A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=924-932&author=L.+Gandhiauthor=M.+W.+Hardingauthor=M.+Neubauerauthor=C.+J.+Langerauthor=M.+Mooreauthor=H.+J.+Rossauthor=B.+E.+Johnsonauthor=T.+J.+Lynch&title=A+phase+II+study+of+the+safety+and+efficacy+of+the+multidrug+resistance+inhibitor+VX-710+combined+with+doxorubicin+and+vincristine+in+patients+with+recurrent+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DNeubauer%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DC.%2BJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DRoss%26aufirst%3DH.%2BJ.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520the%2520safety%2520and%2520efficacy%2520of%2520the%2520multidrug%2520resistance%2520inhibitor%2520VX-710%2520combined%2520with%2520doxorubicin%2520and%2520vincristine%2520in%2520patients%2520with%2520recurrent%2520small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%26date%3D2007%26volume%3D109%26spage%3D924%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Susa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span> </span><span class="NLM_article-title">Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay</span> <span class="citation_source-journal">J. Biomol. Screen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1177%2F1087057109359422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=20150589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFWjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=287-296&author=M.+Susaauthor=E.+Choyauthor=C.+Yangauthor=J.+Schwabauthor=H.+Mankinauthor=F.+Hornicekauthor=Z.+Duan&title=Multidrug+resistance+reversal+agent%2C+NSC77037%2C+identified+with+a+cell-based+screening+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay</span></div><div class="casAuthors">Susa, Michiro; Choy, Edwin; Yang, Cao; Schwab, Joseph; Mankin, Henry; Hornicek, Francis; Duan, Zhenfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-296</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The development of multidrug resistance (MDR) remains a significant obstacle in treating cancer patients with chemotherapy.  To identify small-mol. compds. that can reverse MDR, the authors used a cell-based screening assay with an MDR ovarian cancer cell line.  Incubating MDR cells with a sublethal concn. of paclitaxel in combination with each of 2000 small-mol. compds. from the National Cancer Institute Diversity Set Library, they identified NSC77037.  The cytotoxic activity of NSC77037 and the duration of its effect were evaluated in vitro using a panel of cancer cell lines expressing permeability glycoprotein (Pgp), multiple drug resistance protein 1 (MRP 1), and breast cancer resistance protein (BCRP).  The mechanism of its effects was further analyzed by assessing the retention of calcein and Pgp-ATPase activity.  The relative potency of MDR reversal by NSC77037 was significantly higher than that of frequently used MDR reversal agents such as verapamil and cyclosporine A.  NSC77037 reversed Pgp without reversing MRP or BCRP-mediated MDR.  NSC77037, at a concn. of >10 μM, moderately inhibited the proliferation of both sensitive and resistant cell lines, but the inhibitory effect of NSC77037 was not altered by coincubation with the Pgp inhibitor verapamil, suggesting that NSC77037 itself is not a substrate of Pgp.  NSC77037 directly inhibited the function of Pgp in a dose-dependent manner, but it did not alter the protein expression level of Pgp.  The use of NSC77037 to restore sensitivity to chemotherapy or to prevent resistance could be a potential treatment strategy for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAessbKDM2oLVg90H21EOLACvtfcHk0ljYD-iC6ujXKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFWjsrY%253D&md5=96d4ecfb2baf6e180f0ec3add6bcb47e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1177%2F1087057109359422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109359422%26sid%3Dliteratum%253Aachs%26aulast%3DSusa%26aufirst%3DM.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSchwab%26aufirst%3DJ.%26aulast%3DMankin%26aufirst%3DH.%26aulast%3DHornicek%26aufirst%3DF.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DMultidrug%2520resistance%2520reversal%2520agent%252C%2520NSC77037%252C%2520identified%2520with%2520a%2520cell-based%2520screening%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screen.%26date%3D2010%26volume%3D15%26spage%3D287%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mead, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senear, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepfli, J. B.</span><span> </span><span class="NLM_article-title">The synthesis of potential antimalarials; 2-alkyl-alpha-(2-piperidyl)-4-quinolinemethanols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2708</span><span class="NLM_x">–</span> <span class="NLM_lpage">2710</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01216a088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=2708-2710&author=J.+F.+Meadauthor=A.+E.+Senearauthor=J.+B.+Koepfli&title=The+synthesis+of+potential+antimalarials%3B+2-alkyl-alpha-%282-piperidyl%29-4-quinolinemethanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja01216a088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01216a088%26sid%3Dliteratum%253Aachs%26aulast%3DMead%26aufirst%3DJ.%2BF.%26aulast%3DSenear%26aufirst%3DA.%2BE.%26aulast%3DKoepfli%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520synthesis%2520of%2520potential%2520antimalarials%253B%25202-alkyl-alpha-%25282-piperidyl%2529-4-quinolinemethanols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D2708%26epage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Carson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclay, W. D.</span><span> </span><span class="NLM_article-title">The acylation of polyuronides with formamide as a dispersing agent</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01210a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=1015-1027&author=J.+F.+Carsonauthor=W.+D.+Maclay&title=The+acylation+of+polyuronides+with+formamide+as+a+dispersing+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja01210a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01210a034%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DJ.%2BF.%26aulast%3DMaclay%26aufirst%3DW.%2BD.%26atitle%3DThe%2520acylation%2520of%2520polyuronides%2520with%2520formamide%2520as%2520a%2520dispersing%2520agent%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D1015%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nageshwar, Y. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshram, H. M.</span><span> </span><span class="NLM_article-title">A Facile and Alternative Method for the Synthesis of Mefloquine</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300117u&amp;key=10.1080%2F00397919608003544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADyaK28XisVakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1996&pages=1913-1919&author=M.+S.+Kumarauthor=Y.+V.+D.+Nageshwarauthor=H.+M.+Meshram&title=A+Facile+and+Alternative+Method+for+the+Synthesis+of+Mefloquine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A facile and alternative method for the synthesis of mefloquine</span></div><div class="casAuthors">Kumar, M. Suresh; Nageshwar, Y. V. D.; Meshram, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1913-19</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A convenient and facile synthesis of Mefloquine, based on sulfoxide-Grignard approach is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkWuXe2nlWrbVg90H21EOLACvtfcHk0li_HWzHRhyutA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisVakur4%253D&md5=d4807b64ffae4ab9bad41a1a5890b69a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397919608003544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919608003544%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%2BS.%26aulast%3DNageshwar%26aufirst%3DY.%2BV.%2BD.%26aulast%3DMeshram%26aufirst%3DH.%2BM.%26atitle%3DA%2520Facile%2520and%2520Alternative%2520Method%2520for%2520the%2520Synthesis%2520of%2520Mefloquine%26jtitle%3DSynth.%2520Commun.%26date%3D1996%26volume%3D26%26spage%3D1913%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Solladie-Cavallo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaakoub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azyat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suteu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nafie, L.</span><span> </span><span class="NLM_article-title">A. <i>erythro</i>-1-Naphthyl-1-(2-piperidyl)methanol: synthesis, resolution, NMR relative configuration, and VCD absolute configuration</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7308</span><span class="NLM_x">–</span> <span class="NLM_lpage">7315</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0345502" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=7308-7315&author=A.+Solladie-Cavalloauthor=C.+Marsolauthor=M.+Yaakoubauthor=K.+Azyatauthor=A.+Kleinauthor=M.+Rojeauthor=C.+Suteuauthor=T.+B.+Freedmanauthor=X.+Caoauthor=L.+Nafie&title=A.+erythro-1-Naphthyl-1-%282-piperidyl%29methanol%3A+synthesis%2C+resolution%2C+NMR+relative+configuration%2C+and+VCD+absolute+configuration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo0345502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0345502%26sid%3Dliteratum%253Aachs%26aulast%3DSolladie-Cavallo%26aufirst%3DA.%26aulast%3DMarsol%26aufirst%3DC.%26aulast%3DYaakoub%26aufirst%3DM.%26aulast%3DAzyat%26aufirst%3DK.%26aulast%3DKlein%26aufirst%3DA.%26aulast%3DRoje%26aufirst%3DM.%26aulast%3DSuteu%26aufirst%3DC.%26aulast%3DFreedman%26aufirst%3DT.%2BB.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DNafie%26aufirst%3DL.%26atitle%3DA.%2520erythro-1-Naphthyl-1-%25282-piperidyl%2529methanol%253A%2520synthesis%252C%2520resolution%252C%2520NMR%2520relative%2520configuration%252C%2520and%2520VCD%2520absolute%2520configuration%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D7308%26epage%3D7315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gillespie, R. J.; Lerpiniere, J.; Giles, P. R.; Adams, D. R.; Knutsen, L. J. S.; Cliffe, I. A.</span><span> </span><span class="NLM_article-title">4-Quinolinemethanol derivatives as purine receptor antagonists (II). </span>U.S. Patent 6608085B1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+J.+Gillespie&author=J.+Lerpiniere&author=P.+R.+Giles&author=D.+R.+Adams&author=L.+J.+S.+Knutsen&author=I.+A.+Cliffe&title=4-Quinolinemethanol+derivatives+as+purine+receptor+antagonists+%28II%29.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26atitle%3D4-Quinolinemethanol%2520derivatives%2520as%2520purine%2520receptor%2520antagonists%2520%2528II%2529.%2520%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Carmichael, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraff, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=3802100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=936-942&author=J.+Carmichaelauthor=W.+G.+DeGraffauthor=A.+F.+Gazdarauthor=J.+D.+Minnaauthor=J.+B.+Mitchell&title=Evaluation+of+a+tetrazolium-based+semiautomated+colorimetric+assay%3A+assessment+of+chemosensitivity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a tetrazolium-based semiautomated colorimetric assay:  assessment of chemosensitivity testing</span></div><div class="casAuthors">Carmichael, James; DeGraff, William G.; Gazdar, Adi F.; Minna, John D.; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">936-42</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">Drug sensitivity assays were performed using a variation of a colorimetric thiazolyl blue (MTT)  [298-93-1] assay on V79, CHO-AuxB1, CHRC5, NCI-H460, and NCI-H249 cell lines following optimization of exptl. conditions for each cell line.  Results from this assay were compared with data assimilated simultaneously by clonogenic assay and by dye exclusion assay.  Good correlation was obsd. using the CHO-AuxB1 cell line and the pleiotropic drug-resistant mutant CHRC5, with similar degrees of relative resistance obsd. with both the MTT and clonogenic assays.  Good correlation was obsd. between the clonogenic and MTT assays for 1-h drug exposures, although the MTT assay was more sensitive to vinblastine.  In general, the clonogenic assay was more sensitive when continuous drug exposures were utilized, although this was primarily related to the increased drug exposure time.  While the use of the MTT assay in drug sensitivity testing of primary tumor samples is limited, since contaminating normal cells may also reduce the tetrazolium, the MTT assay can be semiautomated, and therefore it offers a valid, simple method of assessing chemosensitivity in established cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj92XstI7WtLVg90H21EOLACvtfcHk0lix0OKVo8wfsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhsVyrtb0%253D&md5=2414230269c9f4d5f2910764c65fc042</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmichael%26aufirst%3DJ.%26aulast%3DDeGraff%26aufirst%3DW.%2BG.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520a%2520tetrazolium-based%2520semiautomated%2520colorimetric%2520assay%253A%2520assessment%2520of%2520chemosensitivity%2520testing%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D936%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, R. B.</span><span> </span><span class="NLM_article-title">Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1087-1092&author=L.+Huauthor=J.+Hofmannauthor=Y.+Luauthor=G.+B.+Millsauthor=R.+B.+Jaffe&title=Inhibition+of+phosphatidylinositol+3%E2%80%B2-kinase+increases+efficacy+of+paclitaxel+in+in+vitro+and+in+vivo+ovarian+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DJaffe%26aufirst%3DR.%2BB.%26atitle%3DInhibition%2520of%2520phosphatidylinositol%25203%25E2%2580%25B2-kinase%2520increases%2520efficacy%2520of%2520paclitaxel%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520ovarian%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D1087%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaloudek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, R. B.</span><span> </span><span class="NLM_article-title">In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300117u&amp;key=10741711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300117u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=880-886&author=L.+Huauthor=C.+Zaloudekauthor=G.+B.+Millsauthor=J.+Grayauthor=R.+B.+Jaffe&title=In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)</span></div><div class="casAuthors">Hu, Limin; Zaloudek, Charles; Mills, Gordon B.; Gray, Joe; Jaffe, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-886</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase (PI3-K) induces mitogenesis, cell growth, and cell transformation.  Amplification of the gene encoding the P110α subunit likely is an important event in ovarian cancer progression, and PI3-K inhibitors are possible therapeutic agents for this disease.  We evaluated effects of LY294002, a potent inhibitor of PI3-K, on growth of ovarian carcinoma in vivo and in vitro, and on ascites formation in vivo.  Athymic mice were inoculated i.p. with the ovarian cancer cell line OVCAR-3.  Seven days after inoculation, mice were treated with or without LY294002 (100 mg/kg of body wt.) for 3 wk.  Body wt. and abdominal circumference were measured twice weekly.  At the end of the expt., mice were sacrificed, ascites vol. was measured, and tumors were excised.  Mean tumor burden in the LY294002-treated group was reduced by ∼65% vs. controls.  Virtually no ascites developed in the treatment group; mean vol. of ascites in controls was 3.3 ± 0.38 mL.  OVCAR-3 cells also were cultured in vitro without and with LY294002 (1, 5, and 10 μM) for 24 h.  The no. of cells in 1, 5, and 10 μM LY294002-treated wells was reduced by 27, 56, and 75%, resp., vs. controls.  In vivo and in vitro morphol. studies demonstrated that LY294002 induced marked nuclear pyknosis and diminished cytoplasmic vol. in the tumor cells, confirmed as apoptosis.  Thus, LY294002 significantly inhibits growth and ascites formation of ovarian carcinoma in vivo and markedly inhibits ovarian cancer cell proliferation in vitro, suggesting an important role of PI3-K inhibitors as a potentially useful treatment for women with ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuP8ZJJ_717rVg90H21EOLACvtfcHk0lix0OKVo8wfsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVaqtbw%253D&md5=fa194aa4b60b67ca905e77cfd5e0888d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZaloudek%26aufirst%3DC.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%26aulast%3DJaffe%26aufirst%3DR.%2BB.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520ovarian%2520carcinoma%2520growth%2520inhibition%2520by%2520a%2520phosphatidylinositol%25203-kinase%2520inhibitor%2520%2528LY294002%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/jm300117u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14146"></div></div></div></div></div><hr /></hr><p class="last">Perspective views showing 50% probability displacement ellipsoids of absolute configuration for all four isomers (Figure 1). Chiral HPLC spectra of four compounds <b>8</b>, <b>9</b>, <b>10</b> and <b>11</b> (Figure 2). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300117u/suppl_file/jm300117u_si_001.pdf">jm300117u_si_001.pdf (144.24 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300117u&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-7%3Barticle%3Aarticle%3A10.1021%2Fjm300117u%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300117u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679964f84fb73cf4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
